<?xml version="1.0" encoding="UTF-8"?>
<svg height="778.0" width="557.948" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M62.360 53.720 L545.670 53.720 "/>
  <g begin="text">
   <text y="49.34" x="62.362,66.842,71.322,74.862,77.672,82.052,85.182,87.962,92.542,96.922,100.462,104.002,105.882,110.362,115.052,117.832,123.042,125.022,127.802,133.012,138.222,141.002,143.922,148.502,153.712,156.632" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1) </text>
   <text y="49.34" x="530.672,535.672,540.672" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">417</text>
  </g>
  <g begin="text">
   <text y="768.0" x="355.802,363.932,368.622,370.502,373.312,375.192,380.092,381.972,386.352,389.132,393.712,397.562,399.442,403.822,406.952,411.432,414.972,416.852,420.392,423.172,425.572,430.052,434.742,437.872,442.562,447.252" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="768.0" x="449.132,451.912,456.912,461.912,466.912,471.912,474.102,476.882,481.882,486.882,489.072,491.852,495.082,499.662,504.662,507.892,510.672,515.672,520.672,525.672,530.672,535.672,540.672" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285–496</text>
  </g>
  <g begin="text">
   <text y="768.0" x="61.186,68.896,72.746,74.936,77.126,80.976,85.246,89.516,94.306,99.306,104.306,109.206,111.396,115.776,121.296" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M62.360 616.310 L104.620 616.310 "/>
  <g begin="text">
   <text y="77.112" x="62.362,68.365,72.361,76.861,80.362,84.862,87.364,91.864,96.364,98.866,102.367,106.363,110.863,114.859,117.109,123.607,126.109,130.609,135.109,139.609,144.109,147.61,150.112,152.614,156.61,158.86,165.862,168.112,173.116,177.616,181.612,185.113,189.613,194.113,196.615,200.611,202.861,205.111,209.611,214.111,217.612,222.112,226.612,231.112,234.613,236.863,239.113,243.613,249.616,252.118,254.62,258.121,262.117,265.618,268.12,272.62,277.12,281.62,283.87" svgx:width="0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.28,0.39,0.44,0.5,0.44,0.25,0.72,0.28,0.5,0.5,0.5,0.5,0.39,0.28,0.28,0.44,0.25,0.78,0.25,0.56,0.5,0.44,0.39,0.5,0.5,0.28,0.44,0.25,0.25,0.5,0.5,0.39,0.5,0.5,0.5,0.39,0.25,0.25,0.5,0.67,0.28,0.28,0.39,0.44,0.39,0.28,0.5,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Neurologische Diagnostik &amp; Therapie, Sargans, Switzerland, </text>
   <text y="85.592" x="62.362" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">8</text>
   <text y="88.112" x="65.287,71.29,73.792,76.294,80.794,83.296,87.796,92.296,96.292,98.542,102.538,105.04,107.29,112.789,116.785,120.286,126.784,131.284,135.784,139.78,143.776,146.026,150.526,153.523,160.021,164.521,168.517,172.513,174.763,177.013,183.511,188.011,192.007,196.003,198.253,200.503,205.003,211.006,213.508,216.01,219.511,223.507,227.008,229.51,234.01,238.51" svgx:width="0.67,0.28,0.28,0.5,0.28,0.5,0.5,0.44,0.25,0.44,0.28,0.25,0.61,0.44,0.39,0.72,0.5,0.5,0.44,0.44,0.25,0.5,0.33,0.72,0.5,0.44,0.44,0.25,0.25,0.72,0.5,0.44,0.44,0.25,0.25,0.5,0.67,0.28,0.28,0.39,0.44,0.39,0.28,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Clinique et Permance d’Onex, Onex, Switzerland</text>
   <text y="115.112" x="62.362,68.365,72.865,76.861,81.865,86.365,90.199,94.699,99.703,104.707,109.711,112.708" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="115.112" x="114.787,119.971,122.968,126.964,130.96,133.462,140.464,144.46,148.96,151.462,153.541,157.042,161.038,163.54,166.042,169.543,172.54,176.536,180.532,183.034,185.536,190.036,194.536,196.615,200.611,205.111,209.611,211.69,216.19,220.69,224.686,227.188,229.69,232.192,236.692,238.771,243.271,246.268,248.347,250.849,253.351,256.348,260.344,262.423,265.42,271.918,276.418,281.917,284.914,286.993,290.989,293.986,297.982" svgx:width="0.61,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.39,0.44,0.28,0.28,0.39,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.28,0.28,0.33,0.44,0.25,0.33,0.72,0.5,0.61,0.33,0.25,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Treatment satisfaction and quality of life (QoL) are </text>
   <text y="126.11" x="62.362,64.864,71.866,76.366,80.866,83.863,86.365,90.361,94.861,97.363,99.019,103.519,106.021,109.522,113.518,117.514,121.015,125.011,126.667,133.669,137.665,142.165,146.161,150.661,154.657,161.659,165.655,170.155,172.657,174.313,178.813,182.809,185.806,189.802,196.804,200.8,203.302,207.298,210.295,213.796,215.452,217.954,222.454,224.11,230.113,236.116,239.113,247.114,252.118,254.368,256.024,261.028,263.53,268.03,272.53,277.03,279.532,282.034,289.036,293.536,298.036" svgx:width="0.28,0.78,0.5,0.5,0.33,0.28,0.44,0.5,0.28,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.78,0.44,0.5,0.44,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.5,0.44,0.33,0.44,0.78,0.44,0.28,0.44,0.33,0.39,0.25,0.28,0.5,0.25,0.67,0.67,0.33,0.89,0.56,0.25,0.25,0.56,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">important disease management parameters in RR-MS. Fingolimod </text>
   <text y="137.108" x="62.362,65.359,71.857,74.359,76.861,80.857,85.357,89.857,93.853,100.693,103.69,105.94,108.19,111.169,113.671,118.171,122.167,124.417,127.396,130.393,132.895,135.892,139.393,141.895,144.145,147.124,151.624,154.621,158.617,161.119,163.369,166.348,172.351,178.354,181.351,189.352,194.356,196.606,199.585,202.087,205.084,209.08,213.076,215.578,222.58,226.576,231.076,233.578,235.828,238.078,241.057,243.559,247.06,249.31,252.289,256.285,260.785,265.285,268.282,272.782,277.282,281.278,285.778,288.028,291.007,293.509,298.009" svgx:width="0.33,0.72,0.28,0.28,0.44,0.5,0.5,0.44,0.76,0.33,0.25,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.33,0.28,0.33,0.39,0.28,0.25,0.55,0.5,0.33,0.44,0.28,0.25,0.55,0.67,0.67,0.33,0.89,0.56,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.33,0.5,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(Gilenya®), the first oral RR-MS treatment, is approved in </text>
   <text y="148.106" x="62.362,67.366,73.864,76.366,78.868,82.864,86.86,89.857,92.359,96.355,100.855,105.355,107.605,110.17,113.671,116.173,120.673,124.669,128.665,131.23,134.731,138.727,143.227,147.727,151.723,154.72,159.22,161.785,166.285,170.785,174.952,179.452,181.702,184.267,186.769,191.269,193.834,196.831,200.827,205.327,209.827,213.823,217.819,220.384,223.381,226.378,230.374,234.874,239.374,243.37,247.87,251.866,256.366,258.931,263.431,266.428,268.993,271.99,275.986,278.488,282.484,286.984,290.485,294.481,297.982" svgx:width="0.56,0.72,0.28,0.28,0.44,0.44,0.33,0.28,0.44,0.5,0.5,0.25,0.25,0.39,0.28,0.5,0.44,0.44,0.25,0.39,0.44,0.5,0.5,0.44,0.33,0.5,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.28,0.5,0.25,0.33,0.44,0.5,0.5,0.44,0.44,0.25,0.33,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.5,0.33,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Switzerland, since January 2011, to reduce frequency of relapses </text>
   <text y="159.104" x="62.362,66.358,70.858,75.358,77.608,82.108,86.104,88.606,92.602,97.102,99.352,103.852,106.354,109.855,113.851,118.351,120.853,123.355,125.857,128.359,132.859,135.109,139.609,142.606,147.106,151.606,154.603,158.599,162.1,165.601,168.103,172.603,177.103" svgx:width="0.44,0.5,0.5,0.25,0.5,0.44,0.28,0.44,0.5,0.25,0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and delay disability progression.</text>
   <text y="170.102" x="62.362,69.364,74.368,77.365,81.361,85.357,88.354,90.856,95.356,99.352,102.853,105.85" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="170.102" x="109.603,114.607,117.604,122.104,126.604,129.106,133.606,137.602,139.852,141.355,144.352,148.348,152.344,154.846,157.843,164.341,168.841,171.838,174.34,178.84,181.09,182.593,185.095,188.092,192.088,196.084,198.586,205.588,209.584,214.084,216.586,218.836,220.339,223.84,227.836,230.338,232.84,236.341,239.338,243.334,247.33,249.832,252.334,256.834,261.334,263.584,265.087,269.083,273.583,278.083,280.333,281.836,288.334,292.834,298.0" svgx:width="0.56,0.33,0.5,0.5,0.28,0.5,0.44,0.25,0.55,0.33,0.44,0.44,0.28,0.33,0.72,0.5,0.33,0.28,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.39,0.44,0.28,0.28,0.39,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.72,0.5,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Provide real-world treatment satisfaction and QoL </text>
   <text y="181.1" x="62.362,66.862,70.858,73.36,77.356,79.606,80.875,83.872,88.372,91.369,93.619,94.888,99.388,103.384,105.886,108.388,112.384,116.884,119.386,122.887,125.137,126.406,132.904,135.406,137.908,142.408,144.658,145.927,151.93,157.933,160.93,168.931,173.935,176.185,177.454,179.956,182.953,186.949,190.945,193.447,197.443,201.943,204.193,205.462,211.96,214.462,216.964,221.464,223.714,224.983,227.98,230.482,234.982,239.482,243.982,246.484,248.986,255.988,260.488,264.988,267.238,268.507,273.007,276.004,278.254,279.523,284.023,286.525,291.025,295.021,298.018" svgx:width="0.5,0.44,0.28,0.44,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.67,0.67,0.33,0.89,0.56,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.28,0.5,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">data for patients with RR-MS treated with fingolimod or other </text>
   <text y="192.098" x="62.362,68.86,76.861,81.73,85.231" svgx:width="0.72,0.89,0.61,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">DMTs.</text>
   <text y="203.096" x="62.362,70.858,74.854,77.851,82.855,87.355,92.359,95.86,98.857" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="203.096" x="102.403,107.407,111.403,113.905,116.407,120.403,124.903,127.405,130.906,133.156,134.452,140.95,143.452,145.954,150.454,152.704,154.0,160.003,166.006,169.003,177.004,182.008,184.258,185.554,189.55,194.05,198.55,202.051,204.553,209.053,213.049,216.046,218.548,223.048,227.548,229.798,231.094,235.09,237.34,238.636,243.136,247.132,253.63,255.88,257.176,263.674,271.675,277.012,279.262,280.558,287.056,291.052,294.049,298.045" svgx:width="0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.67,0.67,0.33,0.89,0.56,0.25,0.55,0.44,0.5,0.5,0.39,0.28,0.5,0.44,0.33,0.28,0.5,0.5,0.25,0.55,0.44,0.25,0.55,0.5,0.44,0.72,0.25,0.55,0.72,0.89,0.61,0.25,0.55,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Patients with RR-MS considering a new DMT were </text>
   <text y="214.094" x="62.362,64.864,69.364,71.866,75.862,78.859,83.359,85.861,89.857,96.355,100.351,104.851,107.452,111.448,113.95,116.551,121.051,125.047,128.548,132.544,135.046,137.548,142.048,146.044,148.645,151.642,157.645,163.144,166.141,168.742,172.738,177.238,181.738,184.339,187.336,191.836,194.338,196.84,201.34,207.838,210.835,215.335,219.835,222.436,225.433,230.437,236.935,239.185,241.786,245.782,250.282,254.782,259.282,261.784,264.385,268.885,271.486,278.488,282.988,287.488,289.99,294.49,297.991" svgx:width="0.28,0.5,0.28,0.44,0.33,0.5,0.28,0.44,0.72,0.44,0.5,0.25,0.44,0.28,0.25,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.33,0.67,0.61,0.33,0.25,0.44,0.5,0.5,0.25,0.33,0.5,0.28,0.28,0.5,0.72,0.33,0.5,0.5,0.25,0.33,0.56,0.72,0.25,0.25,0.44,0.5,0.5,0.5,0.28,0.25,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">interviewed at baseline (BL) and follow-up (FU, about 6 months </text>
   <text y="225.092" x="62.362,66.358,69.355,71.857,75.853,78.85,81.1,83.053,85.555,88.552,92.548,96.544,99.046,106.048,110.044,114.544,117.046,119.296,121.249,123.751,128.251,130.753,133.255,135.757,139.753,142.255,144.757,149.257,153.757,156.754,159.004,161.254,163.207,169.705,173.701,176.203,180.199,182.449,184.402,188.398,192.898,195.4,197.902,201.898,205.894,208.396,210.898,215.398,219.898,222.148,224.101,230.599,234.595,238.096,240.346,242.299,244.801,249.301,253.801,257.797,262.297,266.293,270.793,275.293,279.289,283.789,286.291,288.541,290.494,294.994,297.991" svgx:width="0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.28,0.5,0.28,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.33,0.25,0.25,0.55,0.72,0.44,0.28,0.44,0.25,0.55,0.44,0.5,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.28,0.5,0.5,0.44,0.5,0.44,0.5,0.5,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">after treatment initiation). Data collection was independent of </text>
   <text y="236.09" x="62.362,64.864,67.861,71.857,75.853,78.355,85.357,89.353,93.853,96.355,98.65,102.646,107.146,111.646,114.148,118.144,122.14,124.39,126.685,131.185,133.687,138.187,140.482,144.982,149.482,151.984,154.279,157.276,161.272,165.772,170.272,172.774,175.771,179.767,182.062,189.064,193.06,197.56,202.06,206.056,208.558,213.058,216.055,220.555,222.85,227.35,229.852,233.353,235.855,238.357,241.858,244.108,246.403,250.399,254.899,259.399,261.694,265.69,268.192,270.694,272.989,276.985,280.486,283.987,287.983,291.484,294.985" svgx:width="0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.44,0.5,0.5,0.28,0.44,0.44,0.25,0.25,0.5,0.28,0.5,0.25,0.5,0.5,0.28,0.25,0.33,0.44,0.5,0.5,0.28,0.33,0.44,0.25,0.78,0.44,0.5,0.5,0.44,0.28,0.5,0.33,0.5,0.25,0.5,0.28,0.39,0.28,0.28,0.39,0.25,0.25,0.44,0.5,0.5,0.25,0.44,0.28,0.28,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">treatment choice, did not require mandatory visits, and all assess-</text>
   <text y="247.088" x="62.362,69.364,73.36,77.86,80.362,83.863,85.969,92.467,96.463,99.46,103.456,105.562,110.062,114.562,119.062,123.058,125.164,129.16,133.156,137.152,141.652,144.649,149.149,151.651,156.151,160.651,162.757,165.259,169.759,171.865,174.367,178.867,182.863,184.969,189.973,196.471,198.973,202.474,205.975,208.081,210.583,214.579,219.079,223.075,225.577,227.827,229.933,234.937,238.933,241.435,243.937,247.933,252.433,254.935,258.436,260.542,264.538,269.038,276.04,280.54,283.042,287.038,289.54,293.536,298.036" svgx:width="0.78,0.44,0.5,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.5,0.5,0.44,0.25,0.44,0.44,0.44,0.5,0.33,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.56,0.72,0.28,0.39,0.39,0.25,0.28,0.44,0.5,0.44,0.28,0.25,0.25,0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.44,0.5,0.78,0.5,0.28,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ments were done according to the Swiss label. Patients completed </text>
   <text y="258.086" x="62.362,64.864,69.364,73.36,75.655,83.656,88.66,91.657,96.661,99.658,104.158,108.658,110.953,114.949,119.449,123.949,126.082,131.581,136.585,143.083,151.084,154.081,158.581,160.876,165.376,169.876,173.872,177.373,179.875,182.377,186.877,191.377,195.877,199.873,202.375,205.372,209.368,212.869,215.164,217.666,222.166,224.461,228.457,231.958,235.459,239.455,242.956,246.457,248.752,251.254,254.251,258.247,262.243,264.745,271.747,275.743,280.243,282.745,285.04,288.541,292.537,295.039" svgx:width="0.28,0.5,0.44,0.25,0.89,0.56,0.33,0.56,0.33,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.61,0.56,0.72,0.89,0.33,0.5,0.25,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.5,0.44,0.28,0.33,0.44,0.39,0.25,0.28,0.5,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.39,0.44,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the MSIS-29 and TSQM-9 questionnaires to assess treatment sat-</text>
   <text y="269.084" x="62.362,64.864,68.365,71.362,75.358,79.354,81.856,84.358,88.858,93.358,96.139,100.135,104.635,109.135,111.916,118.414,122.914,128.413,130.663,133.444,136.441,140.437,143.938,148.438,152.434,156.43,158.932,161.434,165.934,169.93,172.432,176.347,178.597,181.378,185.878,190.378,193.159,196.156,198.658,201.655,205.156,207.658,210.439,214.939,219.439,222.94,226.936,229.717,236.719,241.219,245.719,248.221,250.723,255.223,258.22,260.722,265.222,269.722,272.503,275.5,280.504,287.002,295.003,298.0" svgx:width="0.28,0.39,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.72,0.5,0.61,0.25,0.25,0.33,0.44,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.25,0.5,0.5,0.25,0.33,0.28,0.33,0.39,0.28,0.25,0.5,0.5,0.39,0.44,0.25,0.78,0.5,0.5,0.28,0.28,0.5,0.33,0.28,0.5,0.5,0.25,0.33,0.56,0.72,0.89,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">isfaction and QoL, respectively. 6h first dose monitoring (FDM) </text>
   <text y="280.082" x="62.362,66.862,70.858,73.36,77.356,79.606,86.104,90.1,93.097,97.093,99.343,103.339,107.839,110.341,112.843,116.839,120.835,123.337,127.333,131.833,134.083,137.08,141.58,144.577,146.827,149.824,152.326,156.826,161.326,165.826,168.328,170.83,177.832,182.332,186.832,189.082,191.584,194.581,198.577,202.573,205.075,209.071,213.571,215.821,220.321,224.317,226.819,229.321,233.317,237.817,240.319,243.82" svgx:width="0.5,0.44,0.28,0.44,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.28,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.33,0.5,0.33,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">data were collected for fingolimod treated patients.</text>
   <text y="291.08" x="62.362,68.905,72.946,76.492,81.541,84.088,87.13,90.676,93.718" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="291.08" x="96.283,100.828,105.373,109.918,112.483,117.028,121.069,123.616,126.163,130.204,134.749,137.296,140.842,143.407,146.953,149.5,153.541,156.583,159.13,163.171,167.716,170.281,172.828,175.87,179.911,183.952,186.499,193.546,197.587,202.132,204.679,207.244,213.787,216.334,218.881,223.426,225.991,229.033,231.58,236.125,240.67,245.215,247.762,250.309,257.356,261.901,266.446,268.741,271.306,275.851,280.396,287.938,290.503,295.048,298.045" svgx:width="0.5,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.39,0.28,0.44,0.33,0.28,0.44,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.72,0.28,0.28,0.5,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.25,0.5,0.5,0.83,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">212 patients started treatment with fingolimod. 35% of </text>
   <text y="302.078" x="62.362,66.907,70.948,73.495,76.042,80.083,84.628,87.175,90.721,92.971,94.546,101.089,105.13,108.172,112.213,114.463,116.038,118.585,121.627,125.668,129.709,132.256,139.303,143.344,147.889,150.436,153.478,158.023,162.064,164.611,169.156,173.197,175.492,177.742,179.317,182.359,186.904,189.154,190.729,195.274,199.315,201.862,204.409,208.45,212.995,215.542,219.088,221.338,222.913,229.456,232.003,234.55,239.095,241.345,242.92,247.465,250.507,254.548,259.093,261.64,266.185,270.73,274.276,276.526,278.101,284.644,292.69,298.027" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.33,0.5,0.44,0.28,0.5,0.44,0.25,0.25,0.55,0.33,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.44,0.5,0.28,0.5,0.5,0.39,0.25,0.55,0.72,0.89,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients were treatment-naïve. In patients with previous DMT </text>
   <text y="313.076" x="62.362,65.404,69.949,74.494,82.036,85.078,87.373,90.028,93.07,97.111,101.152,104.698,109.243,113.788,117.334,119.989,123.031,127.576,130.618,133.273,136.819,143.362,145.909,148.456,152.497,157.042,159.589,164.134,168.679,171.334,173.881,178.426,182.467,185.509,189.55,194.095,198.64,201.295,207.838,211.879,214.921,218.962,221.617,226.162,230.203,234.244,238.789,241.336,245.377,248.032,251.074,255.115,257.662,260.209,264.754,269.299,273.34,275.635,278.29,280.837,285.382,287.929,292.474,295.021" svgx:width="0.33,0.5,0.5,0.83,0.33,0.25,0.25,0.33,0.44,0.44,0.39,0.5,0.5,0.39,0.25,0.33,0.5,0.33,0.25,0.39,0.72,0.28,0.28,0.44,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.44,0.44,0.5,0.28,0.44,0.25,0.33,0.44,0.28,0.28,0.5,0.5,0.44,0.25,0.25,0.28,0.5,0.28,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(65%), reasons for switching therapy were needle fatigue, intol-</text>
   <text y="324.074" x="62.362,66.403,69.445,73.486,78.031,82.072,86.113,88.408,90.658,91.405,93.952,97.993,102.034,106.579,108.829,109.576,114.121,117.163,119.413,120.16,124.201,127.081,130.123,132.67,136.711,140.752,144.793,148.753,151.048,153.298,154.045,158.59,163.135,167.68,170.722,172.972,173.719,180.262,184.807,190.018,192.268,193.015,197.056,201.601,206.146,208.396,209.143,212.689,218.737,225.118,227.368,228.115,232.156,236.701,239.248,241.795,246.34,250.885,255.43,257.977,262.018,265.564,267.859,270.109,270.856,275.401,279.946,287.488,289.738,290.485,295.03,298.027" svgx:width="0.44,0.33,0.44,0.5,0.44,0.44,0.25,0.25,0.55,0.28,0.44,0.44,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.33,0.33,0.28,0.44,0.44,0.44,0.5,0.25,0.25,0.55,0.5,0.5,0.5,0.33,0.25,0.55,0.72,0.5,0.61,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.39,0.67,0.72,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.25,0.55,0.5,0.5,0.83,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">erance, lack of efficacy, poor QoL and JCV antibodies. 91% of </text>
   <text y="335.072" x="62.362,66.907,70.948,73.495,76.042,80.083,84.628,87.175,90.721,92.971,93.709,100.252,104.293,107.335,111.376,113.626,114.364,117.406,120.448,124.489,128.53,130.78,131.518,136.063,139.105,141.355,142.093,146.134,150.679,155.224,159.769,162.811,169.858,173.899,176.446,178.696,179.434,184.978,191.026,197.569,199.819,200.557,203.599,206.146,210.691,215.236,217.783,222.328,226.873,230.419,232.669,233.407,237.952,240.994,243.244,243.982,248.023,252.568,257.113,261.154,264.196,267.742,271.783,274.033,274.771,278.812,283.357,287.398,291.943,294.49,297.991" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.33,0.33,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.5,0.33,0.78,0.44,0.28,0.25,0.55,0.61,0.67,0.72,0.25,0.55,0.33,0.28,0.5,0.5,0.28,0.5,0.5,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.44,0.33,0.39,0.44,0.25,0.55,0.44,0.5,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients were free of abnormal ECG findings or adverse events </text>
   <text y="346.07" x="62.362,66.907,71.452,74.494,77.041,81.586,86.131,88.381,89.11,91.657,96.202,100.243,102.493,103.222,108.271,114.814,122.86,125.155,127.405,128.134,132.679,137.224,139.519,144.064,151.606,153.856,154.585,159.13,162.172,164.422,165.151,169.696,173.737,176.284,178.831,182.872,187.417,189.964,193.51,195.76,196.489,200.53,205.075,209.62,212.167,214.714,219.259,223.804,227.845,232.39,234.64,235.369,238.411,240.958,245.503,250.048,254.593,257.14,259.687,266.734,271.279,275.824,278.074,278.803,281.35,284.392,288.433,292.474,295.021" svgx:width="0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.56,0.72,0.89,0.25,0.25,0.55,0.5,0.5,0.25,0.5,0.83,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">during the FDM. 99.5% of patients continued fingolimod treat-</text>
   <text y="357.068" x="62.362,69.409,73.45,77.995,80.542,82.927,86.968,90.01,92.557,96.598,99.64,102.025,104.572,109.117,113.158,115.543,120.592,127.135,135.181,137.476,139.366,145.909,148.456,150.841,155.89,162.433,164.818,167.86,174.907,178.948,182.989,187.534,189.919,194.464,196.759,201.304,203.689,208.675,211.06,215.605,217.9,222.445,224.83,231.877,236.422,240.967,243.514,248.059,251.605,253.99,258.031,261.073,263.62,267.661,270.703,273.088,278.137,284.68,292.726,295.768,298.018" svgx:width="0.78,0.44,0.5,0.28,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.28,0.5,0.44,0.25,0.56,0.72,0.89,0.25,0.25,0.72,0.28,0.25,0.56,0.72,0.25,0.33,0.78,0.44,0.44,0.5,0.25,0.5,0.25,0.5,0.25,0.55,0.25,0.5,0.25,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.56,0.72,0.89,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ment after the FDM. At FU (mean 8.3 ± 3.2 months after FDM), </text>
   <text y="368.066" x="62.362,66.907,71.452,78.994,81.559,86.104,89.146,91.711,96.256,100.297,102.844,105.391,109.432,113.977,116.524,120.07,122.635,126.676,131.221,135.766,138.313,140.86,145.405,149.95,153.991,158.536,161.101,164.143,166.69,171.235,175.78,180.325,182.872,185.419,192.466,197.011,201.556,204.121,206.668,209.71,213.751,217.792,220.339,227.386,231.427,235.972,238.519,240.814,242.884,249.427,251.974,254.521,257.086,261.631,266.176,273.223,277.264,279.811,284.356,287.902,290.467,295.012,298.009" svgx:width="0.5,0.5,0.83,0.25,0.5,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.5,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.25,0.72,0.28,0.28,0.25,0.5,0.5,0.78,0.44,0.28,0.5,0.39,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">96% of patients continued fingolimod treatment. All domains of </text>
   <text y="379.064" x="62.362,64.909,69.454,73.495,75.745,78.157,83.701,88.75,95.293,103.339,106.381,110.926,113.176,115.75,118.792,122.833,125.713,128.755,132.796,136.837,139.384,141.931,146.476,150.517,155.062,159.103,162.649,166.195,168.49,170.74,173.314,177.355,181.9,186.445,190.99,195.031,199.576,202.123,206.164,210.709,214.75,218.791,221.086,223.336,225.91,230.455,233.002,237.547,242.092,246.133,248.68,250.93,253.504,257.05,261.091,263.638,266.185,269.731,272.773,276.814,280.855,283.402,285.949,290.494,295.039,298.036" svgx:width="0.28,0.5,0.44,0.25,0.55,0.61,0.56,0.72,0.89,0.33,0.5,0.25,0.55,0.33,0.44,0.33,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.5,0.44,0.39,0.39,0.25,0.25,0.55,0.44,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.5,0.44,0.44,0.25,0.25,0.55,0.5,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.39,0.44,0.28,0.28,0.39,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the TSQM-9 (effectiveness, convenience, global satisfaction) </text>
   <text y="390.062" x="62.362,65.908,70.453,74.998,81.541,85.582,90.127,92.377,95.284,98.83,101.377,105.922,110.467,113.014,116.056,118.603,122.644,126.685,131.23,133.777,136.027,138.934,141.481,148.528,153.073,156.115,160.66,165.205,169.246,176.293,180.334,184.879,187.426,189.676,192.583,197.128,201.673,206.218,210.763,213.013,215.92,219.466,226.009,228.556,231.103,235.144,239.689,242.236,246.781,251.326,253.576,256.483,259.525,262.567,267.112,274.159,276.409,279.316,283.861,286.408,290.953,294.994,297.991" svgx:width="0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.55,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.5,0.5,0.5,0.25,0.55,0.39,0.72,0.28,0.28,0.44,0.5,0.28,0.5,0.5,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.5,0.28,0.5,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">showed significant improvement upon switching from other </text>
   <text y="401.06" x="62.362,68.905,76.951,81.865,85.411,87.661,88.84,91.387,95.932,98.182,99.361,102.403,104.95,109.495,114.04,118.585,121.132,123.679,130.726,135.271,139.816,142.111,144.361,145.378,150.922,155.467,159.508,161.758,162.937,166.978,169.858,172.9,176.941,180.982,183.529,186.076,190.621,194.662,199.207,203.248,206.794,210.34,212.59,213.769,217.81,222.355,226.9,229.15,230.329,234.874,237.421,241.966,246.511,250.552,253.099,255.349,256.528,260.074,264.115,266.662,269.209,272.755,275.797,279.838,283.879,286.426,288.973,293.518,298.018" svgx:width="0.72,0.89,0.61,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.5,0.44,0.39,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.39,0.44,0.28,0.28,0.39,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">DMTs to fingolimod. The effectiveness and global satisfaction </text>
   <text y="412.058" x="62.362,66.907,71.452,78.499,82.54,85.087,89.632,93.178,95.428,97.327,101.872,104.914,107.164,108.901,114.445,119.494,126.037,134.083,137.125,141.67,143.92,145.819,152.362,156.403,159.445,163.486,165.736,167.635,171.676,176.221,183.268,187.813,191.854,194.896,198.937,203.482,206.029,210.07,212.32,214.219,216.766,221.311,223.561,225.46,230.005,234.55,237.097,241.642,243.892,245.791,249.337,255.88,258.427,260.974,265.015,269.56,271.81,273.709,277.75,282.295,286.84,289.09,290.989,293.536,298.036" svgx:width="0.5,0.5,0.78,0.44,0.28,0.5,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.61,0.56,0.72,0.89,0.33,0.5,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.28,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.28,0.5,0.25,0.55,0.39,0.72,0.28,0.28,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">domains of TSQM-9 were comparable in both switch and in </text>
   <text y="423.056" x="62.362,64.909,67.951,71.992,76.033,78.58,85.627,89.668,94.213,96.76,99.802,104.347,108.388,110.935,115.48,119.521,121.636,126.181,130.222,132.769,135.316,139.357,143.902,146.449,149.995,152.29,154.405,157.951,162.496,167.041,171.586,175.627,179.173,181.72,184.267,188.812,192.853,194.968,199.513,202.555,204.661,209.206,211.753,216.298,220.843,222.958,226.504,230.545,233.092,235.639,239.185,242.227,246.268,250.309,252.856,255.403,259.948,264.493,266.608,273.151,275.698,278.245,282.79,284.905,287.947,290.494,295.039" svgx:width="0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.33,0.5,0.44,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.39,0.5,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.25,0.5,0.33,0.25,0.5,0.28,0.5,0.5,0.25,0.39,0.44,0.28,0.28,0.39,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.33,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">treatment-naïve patients, suggestive of high satisfaction with fin-</text>
   <text y="434.054" x="62.362,66.907,71.452,73.999,76.546,83.593,88.138,92.683,95.059,97.606,100.648,104.689,108.73,111.277,118.324,122.365,126.91,129.457,131.833,134.38,138.925,141.301,145.846,150.391,152.938,157.483,159.859,162.406,166.951,171.496,175.537,179.083,181.459,186.004,189.046,191.422,195.967,200.008,202.555,205.102,209.143,213.688,216.235,219.781,222.076,224.452,230.995,235.54,240.751,243.127,246.169,248.716,253.261,255.808,259.849,262.396,264.772,272.818,277.867,280.909,285.958,289.0,293.545,298.045" svgx:width="0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.28,0.5,0.25,0.5,0.5,0.28,0.5,0.25,0.28,0.5,0.5,0.44,0.39,0.25,0.5,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.72,0.5,0.61,0.25,0.33,0.28,0.5,0.28,0.44,0.28,0.25,0.89,0.56,0.33,0.56,0.33,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">golimod treatment in both types of patients. QoL (total MSIS-29 </text>
   <text y="445.052" x="62.362,65.908,69.949,74.494,77.536,81.577,84.619,86.869,89.173,92.215,96.256,103.303,107.344,109.891,114.436,118.477,123.022,125.272,127.576,131.617,136.162,140.707,144.253,146.8,150.841,155.386,157.933,160.183,162.487,165.034,169.579,171.829,174.133,178.678,183.223,185.77,190.315,192.565,194.869,198.415,204.958,207.505,210.052,214.093,218.638,220.888,223.192,227.233,231.778,236.323,238.573,240.877,243.424,246.466,250.507,254.548,257.095,264.142,268.183,272.728,275.275,278.317,282.862,286.903,289.45,293.995,297.991" svgx:width="0.39,0.44,0.5,0.33,0.44,0.33,0.25,0.55,0.33,0.44,0.78,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.39,0.28,0.44,0.5,0.28,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.28,0.5,0.25,0.55,0.39,0.72,0.28,0.28,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.33,0.5,0.44,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">score) remained constant in both switch and treatment-naïve </text>
   <text y="456.05" x="62.362,66.907,70.948,73.495,76.042,80.083,84.628,87.175,90.721,92.971,95.221,99.766,104.311,107.353,109.9,114.445,118.99,121.24,123.49,126.037,129.079,133.12,137.161,139.708,146.755,150.796,155.341,157.888,160.138,162.388,168.931,171.478,174.025,178.57,180.82,183.07,186.112,188.659,193.204,197.749,202.294,204.841,207.388,214.435,218.98,223.525,225.82,228.07,230.32,236.863,239.41,241.957,246.502,248.752,251.002,255.043,257.293,259.543,263.089,265.636,270.181,274.726,277.273,280.315,282.862,286.903,290.944,295.489,297.991" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients during treatment with fingolimod, with a significant </text>
   <text y="467.048" x="62.362,64.909,71.956,76.501,79.543,84.088,88.633,92.674,99.721,103.762,108.307,110.854,113.77,118.315,121.357,124.273,126.82,131.365,135.406,138.322,145.369,149.41,153.955,156.502,160.543,163.09,166.006,169.552,174.097,178.642,182.188,186.229,190.774,193.816,197.857,200.773,203.32,207.865,210.781,215.326,219.367,221.914,224.461,228.502,233.047,235.594,239.14,242.056,245.602,252.145,254.692,257.239,261.28,265.825,268.372,272.917,277.462,280.378,283.42,286.462,291.007,298.009" svgx:width="0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.78,0.44,0.5,0.28,0.44,0.28,0.25,0.39,0.5,0.5,0.39,0.44,0.5,0.33,0.44,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.39,0.72,0.28,0.28,0.44,0.5,0.28,0.5,0.5,0.25,0.33,0.33,0.5,0.78,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">improvement of the mental subscore in patients switching from </text>
   <text y="478.046" x="62.362,66.907,69.454,73.999,78.04,81.082,83.467,90.01,98.056,102.97,106.516,108.91,111.457,116.002,118.387,121.429,123.976,128.521,133.066,137.611,140.158,142.705,149.752,154.297,158.842,161.137,163.522,170.065,174.61,177.652,180.199,184.744,189.289,191.683,196.732,203.275,205.57,207.955,212.5,217.045,224.587,226.972,231.517,234.559,236.944,241.489,245.53,248.077,250.624,254.665,259.21,261.757,265.303,267.688,270.73,274.771,279.316,283.861,286.903,289.45,293.491,297.991" svgx:width="0.5,0.28,0.5,0.44,0.33,0.25,0.72,0.89,0.61,0.39,0.25,0.28,0.5,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.25,0.72,0.5,0.33,0.28,0.5,0.5,0.25,0.56,0.72,0.25,0.25,0.5,0.5,0.83,0.25,0.5,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">other DMTs to fingolimod. During FU, 12% of patients reported </text>
   <text y="489.044" x="62.362,66.403,70.948,75.493,79.534,82.576,86.122,90.163,92.413,94.06,98.101,102.646,106.687,111.232,113.779,117.325,119.575,121.222,124.264,128.305,130.852,133.399,135.649,137.296,141.841,146.386,150.931,153.973,157.519,161.56,164.602,167.149,171.694,176.239,179.785,182.827,185.122,187.372,189.019,191.566,196.111,200.152,202.699,207.244,211.789,214.336,218.881,223.426,225.676,227.323,231.868,236.413,240.454,242.704,244.351,248.896,252.937,255.484,258.031,262.072,266.617,269.164,271.414,273.061,276.103,280.648,282.943,287.488,295.03,298.027" svgx:width="0.44,0.5,0.5,0.44,0.33,0.39,0.44,0.25,0.55,0.44,0.5,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.44,0.28,0.28,0.25,0.55,0.5,0.5,0.5,0.33,0.39,0.44,0.33,0.28,0.5,0.5,0.39,0.33,0.25,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.25,0.55,0.33,0.5,0.25,0.5,0.83,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">adverse events (all non-serious), including one patient (0.5%) </text>
   <text y="500.042" x="62.362,68.905,71.452,73.999,78.544,80.461,87.508,91.549,95.59,100.135,102.682,106.723,109.765,111.682,116.227,120.268,124.813,128.854,135.901,139.942,142.237,143.659,150.202,156.25,162.298,164.215,168.76,172.801,176.842,179.884,183.925,187.966,191.512,195.553,200.098,202.015,205.057,208.099,212.644,219.691,221.608,226.153,228.448,232.993,234.91,239.896,241.813,246.358,248.653,253.198,255.115,257.662,262.207,264.124,268.669,270.964,275.509,277.426,282.412,284.329,288.874,291.169,295.714" svgx:width="0.72,0.28,0.28,0.5,0.25,0.78,0.44,0.44,0.5,0.28,0.44,0.33,0.25,0.5,0.44,0.5,0.44,0.78,0.44,0.25,0.25,0.72,0.67,0.67,0.25,0.5,0.44,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.33,0.33,0.5,0.78,0.25,0.5,0.25,0.5,0.25,0.55,0.25,0.5,0.25,0.5,0.25,0.28,0.5,0.25,0.5,0.25,0.5,0.25,0.55,0.25,0.5,0.25,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">with macular oedema. ARR decreased from 0.8 ± 1.0 to 0.2 ± 0.9.</text>
   <text y="511.04" x="62.362,68.86,73.36,78.364,82.36,84.862,89.866,93.367,95.869,100.369,105.373,108.874,111.871" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="511.04" x="114.571,117.568,122.068,124.768,127.27,131.77,134.272,137.773,140.473,143.47,147.466,151.462,153.964,156.961,163.459,167.959,170.956,173.458,177.958,180.658,184.159,188.155,190.657,193.159,195.661,200.161,204.661,206.911,209.611,213.607,216.442,219.439,221.941,225.937,229.933,233.929,237.844,240.094,242.794,245.296,249.796,252.298,256.294,259.291,263.287,267.787,270.289,272.791,275.293,277.795,282.295,284.995,288.991,293.491,297.991" svgx:width="0.33,0.5,0.25,0.28,0.5,0.28,0.39,0.25,0.33,0.44,0.44,0.28,0.33,0.72,0.5,0.33,0.28,0.5,0.25,0.39,0.44,0.28,0.28,0.28,0.5,0.5,0.25,0.25,0.44,0.33,0.33,0.28,0.44,0.44,0.44,0.5,0.25,0.25,0.28,0.5,0.28,0.44,0.33,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">In this real-world setting, efficacy, tolerability and </text>
   <text y="522.038" x="62.362,65.863,69.859,72.856,76.852,79.354,83.854,86.104,87.049,91.549,94.546,96.796,97.741,100.738,103.24,107.74,112.24,116.74,119.242,121.744,128.746,133.246,137.746,139.996,140.941,147.439,151.435,154.432,158.428,160.678,161.623,164.125,168.625,170.875,171.82,174.322,176.824,181.324,185.32,187.57,188.515,195.013,197.515,200.017,204.517,206.767,207.712,212.212,216.208,218.71,222.706,224.956,225.901,228.898,232.894,237.394,241.894,244.891,247.393,251.389,255.889,258.139,259.084,261.586,266.086,268.336,269.281,274.285,278.785,282.781,286.282,290.278,292.528,293.473,297.973" svgx:width="0.39,0.44,0.33,0.44,0.28,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.28,0.5,0.44,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.25,0.55,0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.56,0.5,0.44,0.39,0.44,0.25,0.55,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">safety of fingolimod were in line with data reported in Phase 3 </text>
   <text y="533.036" x="62.362,64.864,67.861,70.363,74.359,76.861,80.362,82.612,84.862,86.059,91.243,94.24,98.236,102.232,104.734,111.736,115.732,120.232,122.734,124.984,126.343,129.844,133.84,136.342,138.844,142.345,145.342,149.338,153.334,155.836,158.338,162.838,167.338,169.588,170.947,177.445,179.947,182.449,186.949,189.199,190.558,193.555,196.057,200.557,205.057,209.557,212.059,214.561,221.563,226.063,230.563,232.813,234.172,240.67,244.666,248.167,250.417,251.776,256.276,258.778,263.278,267.778,270.028,271.387,273.889,278.389,280.639,281.998,286.498,290.998,293.5,298.0" svgx:width="0.28,0.33,0.28,0.44,0.28,0.39,0.25,0.25,0.55,0.61,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.39,0.44,0.28,0.28,0.39,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">trials. Treatment satisfaction with fingolimod was high in both </text>
   <text y="544.034" x="62.362,64.864,67.861,71.857,75.853,78.355,85.357,89.353,93.853,96.355,99.352,103.852,107.848,110.35,114.85,118.846,121.096,121.96,125.956,130.456,134.956,137.206,138.07,141.571,148.069,150.571,153.073,157.069,161.569,163.819,164.683,169.183,173.179,175.681,178.183,182.179,186.679,189.181,192.682,194.932,197.182,198.046,204.544,209.044,211.546,214.048,218.044,220.294,221.158,227.656,232.156,237.322,239.572,240.436,243.433,247.429,254.431,258.427,260.929,265.429,269.425,273.925,276.175,277.039,280.54,283.042,287.038,291.538,294.04,298.036" svgx:width="0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.33,0.5,0.44,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.39,0.72,0.28,0.28,0.44,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.55,0.72,0.5,0.28,0.28,0.44,0.25,0.55,0.72,0.5,0.61,0.25,0.55,0.33,0.44,0.78,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.39,0.28,0.44,0.5,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">treatment-naïve and switch patients, while QoL remained stable </text>
   <text y="555.032" x="62.362,66.862,71.362,75.358,78.355,80.605,83.107,87.607,91.603,93.853,100.855,104.851,108.847,113.347,115.597,118.594,123.094,125.596,128.098,132.598,139.096,142.093,146.593,151.093,153.343,157.843,161.839,164.836,167.338,171.838,176.338,178.588,183.088,186.085,188.335,192.835,195.085,199.585,201.835,208.837,213.337,217.837,220.339,224.839,228.34" svgx:width="0.5,0.5,0.44,0.33,0.25,0.28,0.5,0.44,0.25,0.78,0.44,0.44,0.5,0.25,0.33,0.5,0.28,0.28,0.5,0.72,0.33,0.5,0.5,0.25,0.5,0.44,0.33,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.25,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">over the mean follow-up period of 8.3 months.</text>
   <text y="582.032" x="62.362,67.861,72.361,76.861" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P798</text>
   <text y="593.03" x="62.362,68.86,73.36,76.861,80.857,85.861,88.111,92.611,97.615,102.115,104.617,109.117,112.618,115.12,118.621,120.871,125.371,128.368,130.618,133.615,138.619,142.615,144.865,153.865,160.867,167.869,170.119,176.617,179.119,182.62,187.12,192.124,194.626,197.128,199.63,202.627,207.127,209.377,215.875,219.376,222.877,226.873,230.374,233.875,241.372,245.368,250.372,253.369" svgx:width="0.72,0.5,0.39,0.44,0.56,0.25,0.5,0.56,0.5,0.28,0.5,0.39,0.28,0.39,0.25,0.5,0.33,0.25,0.33,0.56,0.44,0.25,1.0,0.78,0.78,0.25,0.72,0.28,0.39,0.5,0.56,0.28,0.28,0.28,0.33,0.5,0.25,0.72,0.39,0.39,0.44,0.39,0.39,0.83,0.44,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Rasch analysis of the WHO Disability Assessment </text>
   <text y="604.028" x="62.362,67.366,71.362,76.366,80.362,85.366,90.37,92.872,96.868,99.118,103.618,105.868,110.368,112.618,115.615,120.115,124.111,126.361,131.365,134.866,138.862,141.112,143.614,148.618,150.868,158.365,163.369,165.871,168.868,171.37,176.374,178.876,182.872,185.122,188.623,192.619,195.121,199.117,203.113,207.613,211.114,213.616" svgx:width="0.56,0.44,0.56,0.44,0.56,0.56,0.28,0.44,0.25,0.5,0.25,0.5,0.25,0.33,0.5,0.44,0.25,0.56,0.39,0.44,0.25,0.28,0.56,0.25,0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Schedule 2.0 for use in multiple sclerosis</text>
   <text y="615.026" x="62.362,68.365,71.866,74.116,80.614,83.116,87.616,92.116,96.616,101.116" svgx:width="0.67,0.39,0.25,0.72,0.28,0.5,0.5,0.5,0.5,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CJ Gibbons</text>
   <text y="612.592" x="104.617" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="615.112" x="107.542,109.792,112.042,118.045,120.295,128.296,130.798,133.3,135.802" svgx:width="0.25,0.25,0.67,0.25,0.89,0.28,0.28,0.28,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, R Mills</text>
   <text y="612.592" x="139.303" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="615.112" x="142.228,144.478,146.728,153.226,155.476,160.975,164.971,169.471,173.971,177.967,182.467" svgx:width="0.25,0.25,0.72,0.25,0.61,0.44,0.5,0.5,0.44,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Tennant</text>
   <text y="612.592" x="184.968" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="615.112" x="187.893,190.143,192.393,198.396,200.646,207.144,211.644,216.144,220.644" svgx:width="0.25,0.25,0.67,0.25,0.72,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, C Young</text>
   <text y="612.592" x="225.144,228.069,229.531" svgx:width="0.5,0.25,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">4,5</text>
   <text y="615.112" x="232.456,234.706,236.956,242.455,248.953,255.451,257.953,263.956" svgx:width="0.25,0.25,0.61,0.72,0.72,0.28,0.67,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, TONiC </text>
   <text y="626.11" x="62.365,67.369,69.871,74.371,78.871,83.371,85.621,92.119,95.116,99.616,104.116" svgx:width="0.56,0.28,0.5,0.5,0.5,0.25,0.72,0.33,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Study Group</text>
   <text y="634.592" x="62.362" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="637.112" x="65.287,71.785,76.285,78.787,82.783,86.779,90.28,93.781,96.283,98.785,102.781,105.031,109.531,112.033,114.283,121.78,126.28,130.78,134.776,139.276,143.272,146.773,149.275,153.271,156.772,159.022,161.272,167.275,170.272,176.77,182.269,184.519,190.522,195.526,201.025,207.523,213.022,219.025,222.022,228.52,236.017,238.267,240.517,248.014,252.514,257.014,261.01,265.51,269.506,273.007,275.509,279.505,283.006,285.256" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.83,0.5,0.5,0.44,0.5,0.44,0.39,0.28,0.44,0.39,0.25,0.25,0.67,0.33,0.72,0.61,0.25,0.67,0.56,0.61,0.72,0.61,0.67,0.33,0.72,0.83,0.25,0.25,0.83,0.5,0.5,0.44,0.5,0.44,0.39,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of Manchester, NIHR CLAHRC-GM, Manchester, </text>
   <text y="648.11" x="62.362,68.86,73.36,75.862,78.364,82.36,86.86,89.11,95.113,97.615,102.115,106.615,111.115,115.615,122.113,124.363" svgx:width="0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.67,0.28,0.5,0.5,0.5,0.5,0.72,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">United Kingdom, </text>
   <text y="645.592" x="126.613" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="648.112" x="129.538,135.037,139.537,143.533,148.033,150.535,152.785,158.284,161.785,165.781,169.282,171.784,176.284,180.784,183.034,189.532,194.032,197.533,202.033,204.535,207.037,211.537,214.039,216.289,218.539,224.038,227.539,231.535,235.036,237.538,242.038,246.538,248.788,251.038,257.536,262.036,264.538,267.04,271.036,275.536" svgx:width="0.61,0.5,0.44,0.5,0.28,0.25,0.61,0.39,0.44,0.39,0.28,0.5,0.5,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.25,0.61,0.39,0.44,0.39,0.28,0.5,0.5,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Royal Preston Hospital, Preston, United </text>
   <text y="659.11" x="62.362,68.365,70.867,75.367,79.867,84.367,88.867,95.365,97.615" svgx:width="0.67,0.28,0.5,0.5,0.5,0.5,0.72,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Kingdom, </text>
   <text y="656.592" x="99.865" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="659.112" x="102.79,109.288,113.788,116.29,120.286,124.282,127.783,131.284,133.786,136.288,140.284,142.534,147.034,149.536,151.786,156.79,160.786,164.782,169.282,172.783,175.033,177.283,182.287,186.283,190.279,194.779,198.28,200.53,202.78,209.278,213.778,216.28,218.782,222.778,227.278,229.528,235.531,238.033,242.533,247.033,251.533,256.033,262.531,264.781" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.56,0.44,0.44,0.5,0.39,0.25,0.25,0.56,0.44,0.44,0.5,0.39,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.67,0.28,0.5,0.5,0.5,0.5,0.72,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of Leeds, Leeds, United Kingdom, </text>
   <text y="656.592" x="267.029" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">4</text>
   <text y="659.112" x="269.954,274.958,279.458,283.454" svgx:width="0.56,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">The </text>
   <text y="670.11" x="62.36,69.857,74.357,76.859,79.361,83.861,88.361,90.611,96.614,100.61,105.11,107.612,111.113,115.109,117.359,122.858,127.358,131.858,136.358,140.858,145.358,147.86,150.362,154.862,159.362,161.612,166.616,170.117,174.617,178.118,180.62,182.87,185.12,190.124,192.626,196.622,200.618,204.119,208.619,213.119,217.619,220.121,222.371,224.621,231.119,235.619,238.121,240.623,244.619,249.119,251.369,257.372,259.874,264.374,268.874,273.374,277.874,284.372,286.622" svgx:width="0.83,0.5,0.28,0.28,0.5,0.5,0.25,0.67,0.44,0.5,0.28,0.39,0.44,0.25,0.61,0.5,0.5,0.5,0.5,0.5,0.28,0.28,0.5,0.5,0.25,0.56,0.39,0.5,0.39,0.28,0.25,0.25,0.56,0.28,0.44,0.44,0.39,0.5,0.5,0.5,0.28,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.67,0.28,0.5,0.5,0.5,0.5,0.72,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Walton Centre Foundation Trust, Liverpool, United Kingdom, </text>
   <text y="678.592" x="62.362" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">5</text>
   <text y="681.112" x="65.287,71.785,76.285,78.787,82.783,86.779,90.28,93.781,96.283,98.785,102.781,105.031,109.531,112.033,114.283,119.287,121.789,125.785,129.781,133.282,137.782,142.282,146.782,149.284,151.534,153.784,158.788,161.29,165.286,169.282,172.783,177.283,181.783,186.283,188.785,191.035,193.285,199.783,204.283,206.785,209.287,213.283,217.783,220.033,226.036,228.538,233.038,237.538,242.038,246.538" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.56,0.28,0.44,0.44,0.39,0.5,0.5,0.5,0.28,0.25,0.25,0.56,0.28,0.44,0.44,0.39,0.5,0.5,0.5,0.28,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.67,0.28,0.5,0.5,0.5,0.5,0.72" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of Liverpool, Liverpool, United Kingdom</text>
   <text y="708.112" x="62.362,68.365,72.865,76.861,81.865,86.365,90.199,94.699,99.703,104.707,109.711,112.708" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="708.112" x="117.415,122.914,127.414,131.41,133.66,135.955,144.451,150.949,157.447,159.697,162.154,168.652,171.154,174.655,178.651,183.151,185.653,188.155,190.657,193.159,197.659,199.909,201.871,208.369,211.87,215.371,219.367,222.868,226.369,233.371,237.367,241.867,244.369,246.619,249.076,254.08,258.076,262.576,266.572,271.072,275.572,278.074,282.07,284.32,286.777,291.277,293.527,298.027" svgx:width="0.61,0.5,0.44,0.25,0.55,0.94,0.72,0.72,0.25,0.55,0.72,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.72,0.39,0.39,0.44,0.39,0.39,0.78,0.44,0.5,0.28,0.25,0.55,0.56,0.44,0.5,0.44,0.5,0.5,0.28,0.44,0.25,0.55,0.5,0.25,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The WHO Disability Assessment Schedule 2.0 </text>
   <text y="719.11" x="62.362,65.359,73.855,80.353,86.851,93.349,99.847,104.851,107.848,110.845,113.842,116.839,119.656,122.158,125.659,128.476,132.472,135.289,139.789,143.785,148.285,152.281,155.278,157.78,161.776,164.593,169.093,173.593,177.589,181.09,183.592,186.094,190.594,195.094,199.594,203.59,206.092,209.089,213.085,215.902,218.404,222.904,226.9,229.402,232.219,236.215,239.716,243.217,247.213,250.714,254.215,258.211,261.712,264.529,269.029,271.531,275.032,279.028,283.528,286.03,288.532,291.034,293.536,298.036" svgx:width="0.33,0.94,0.72,0.72,0.72,0.72,0.56,0.33,0.33,0.33,0.33,0.25,0.28,0.39,0.25,0.44,0.25,0.5,0.44,0.5,0.44,0.33,0.28,0.44,0.25,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.5,0.44,0.28,0.33,0.44,0.25,0.28,0.5,0.44,0.28,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.44,0.39,0.25,0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(WHODAS-II) is a generic questionnaire that assesses disability </text>
   <text y="730.108" x="62.362,66.358,70.354,73.351,77.851,81.352,84.853,87.103,91.603,96.103,103.105,107.101,109.603,114.103,117.604,119.854,122.356,126.856,130.852,133.354,137.854,142.354,144.856,149.356,153.856,156.106,160.102,164.602,169.102,173.602,176.104,178.606,181.108,185.608,190.108,192.358,194.608,198.109,202.105,204.607,207.604,210.601,214.597,218.593,221.59,225.586,227.836,231.832,236.332,240.832,243.082,247.582,251.578,254.575,257.077,259.579,263.575,266.077,270.577,274.573,277.075,279.577,284.077,288.577" svgx:width="0.44,0.44,0.33,0.5,0.39,0.39,0.25,0.5,0.5,0.78,0.44,0.28,0.5,0.39,0.25,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.25,0.39,0.44,0.28,0.33,0.33,0.44,0.44,0.33,0.44,0.25,0.44,0.5,0.5,0.25,0.5,0.44,0.33,0.28,0.28,0.44,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">across domains including cognition, self-care and participation.</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M310.020 540.300 L346.260 540.300 "/>
  <g begin="text">
   <text y="77.103" x="310.016,317.018,322.022,325.019,329.015,333.011,336.008,338.51,343.01,347.006,350.507,353.504" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="77.103" x="357.401,362.9,367.4,371.396,373.646,375.293,379.289,383.789,386.786,389.783,393.779,398.279,400.781,403.031,404.678,408.179,410.681,415.181,419.681,424.181,426.431,428.078,432.074,436.574,440.57,443.072,447.572,451.568,454.07,458.066,462.566,464.816,466.463,468.965,473.465,477.461,479.711,481.358,484.859,489.359,491.861,494.363,498.359,502.859,505.361,507.863,510.365,512.867,517.367,519.617,521.264,525.764,528.761,531.011,532.658,535.16,539.66,542.162,545.663" svgx:width="0.61,0.5,0.44,0.25,0.55,0.44,0.5,0.33,0.33,0.44,0.5,0.28,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.5,0.28,0.28,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The current study evaluated the suitability of this </text>
   <text y="88.101" x="310.016,317.018,321.014,325.01,328.511,333.011,336.008,340.004,342.272,345.269,349.769,352.766,355.034,359.534,363.035,367.031,369.299,371.801,376.301,378.569,385.571,390.071,392.573,395.075,397.577,402.077,404.579,408.575,410.843,414.344,418.34,420.842,424.838,427.835,432.335,435.836,438.338,441.839,444.107,447.104,455.105,460.109,463.106,465.374,469.874,474.374,476.642,480.638,485.138,489.638,492.14,496.64,499.142,503.642,508.142,510.41,513.911,517.907,521.903,524.405,528.401,530.669,535.169,539.165,541.667,545.663" svgx:width="0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.25,0.33,0.5,0.33,0.25,0.5,0.39,0.44,0.25,0.28,0.5,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.33,0.89,0.56,0.33,0.25,0.5,0.5,0.25,0.44,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.25,0.39,0.44,0.44,0.28,0.44,0.25,0.5,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">measure for use in multiple sclerosis (MS) by applying scale data </text>
   <text y="99.099" x="310.016,312.518,317.018,319.268,321.77,326.27,330.266,332.516,338.519,342.515,346.016,350.012,354.512,356.762,363.764,368.264,372.764,376.76,379.262,381.512,383.762,387.758,390.008,397.01,401.51,406.01,410.006,413.003,417.503,419.753,424.253,427.754,432.254,436.25,440.75,445.25,452.252,456.248,458.75,461.747,464.249,468.245,470.495,472.997,476.993,480.989,485.489,489.989,492.491,496.991,501.491,505.487" svgx:width="0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.67,0.44,0.39,0.44,0.5,0.25,0.78,0.5,0.5,0.44,0.28,0.25,0.25,0.44,0.25,0.78,0.5,0.5,0.44,0.33,0.5,0.25,0.5,0.39,0.5,0.44,0.5,0.5,0.78,0.44,0.28,0.33,0.28,0.44,0.25,0.28,0.44,0.44,0.5,0.5,0.28,0.5,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">to the Rasch model, a modern psychometric technique.</text>
   <text y="110.097" x="310.016,318.467,322.418,325.37,330.329,334.784,339.743,343.199,346.151" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="110.097" x="349.265,354.224,358.175,360.632,363.089,367.04,371.495,373.952,377.408,379.658,380.522,383.474,389.927,394.958,399.413,403.868,408.323,411.275,413.525,414.389,420.842,424.793,427.745,431.696,433.946,434.81,438.761,443.216,447.671,451.127,455.078,459.029,463.484,465.941,468.398,472.853,476.804,479.261,483.716,485.966,486.83,490.781,495.236,499.69,502.642,507.097,511.048,514.999,519.454,523.405,527.86,530.11,530.974,535.43,539.885,542.666" svgx:width="0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.72,0.56,0.5,0.5,0.5,0.33,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.44,0.5,0.5,0.39,0.44,0.44,0.5,0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.33,0.5,0.44,0.44,0.5,0.44,0.5,0.25,0.55,0.5,0.5,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Patients (N=401) were consecutively approached dur-</text>
   <text y="121.095" x="310.007,312.464,316.919,321.374,323.624,326.252,329.204,333.659,338.114,340.571,343.028,347.483,351.434,353.684,356.312,360.263,362.72,365.177,369.632,372.089,376.04,378.29,380.918,384.868,389.323,393.778,398.233,400.69,405.145,407.602,414.559,418.51,422.965,425.422,428.878,431.128,433.756,437.707,441.658,444.61,449.065,452.521,455.977,458.227,460.855,463.312,467.767,470.719,474.67,478.621,480.871,483.499,486.955,489.412,491.869,495.82,499.276,501.526,504.154,506.611,511.066,513.316,515.944,521.398,525.853,530.308,532.765,536.716,541.171,545.671" svgx:width="0.28,0.5,0.5,0.25,0.55,0.33,0.5,0.5,0.28,0.28,0.5,0.44,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.44,0.5,0.5,0.5,0.28,0.5,0.28,0.78,0.44,0.5,0.28,0.39,0.25,0.55,0.44,0.44,0.33,0.5,0.39,0.39,0.25,0.55,0.28,0.5,0.33,0.44,0.44,0.25,0.55,0.39,0.28,0.28,0.44,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.61,0.5,0.5,0.28,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ing routine clinic appointments across three sites in England </text>
   <text y="132.093" x="310.007,312.959,318.413,320.87,325.325,329.276,332.228,336.683,341.138,345.593,348.05,350.255,352.622,357.581,360.533,364.484,367.94,370.397,374.852,379.307,381.512,383.879,388.838,392.789,395.246,398.198,402.653,405.605,410.06,413.012,415.216,417.583,422.543,426.493,428.951,431.408,435.358,439.813,442.27,445.726,448.093,454.546,458.497,461.449,465.4,467.767,471.223,475.174,479.629,482.086,484.453,486.91,491.365,495.316,497.521,505.972,512.425,518.878,525.331,531.784,536.743,539.695,542.647,545.644" svgx:width="0.33,0.61,0.28,0.5,0.44,0.33,0.5,0.5,0.5,0.28,0.25,0.25,0.56,0.33,0.44,0.39,0.28,0.5,0.5,0.25,0.25,0.56,0.44,0.28,0.33,0.5,0.33,0.5,0.33,0.25,0.25,0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.39,0.44,0.5,0.28,0.25,0.28,0.5,0.44,0.25,0.94,0.72,0.72,0.72,0.72,0.56,0.33,0.33,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(Liverpool, Preston, Salford). Patients were sent the WHODAS-II </text>
   <text y="143.091" x="310.007,314.462,318.917,322.868,326.324,328.781,331.238,335.693,340.148,344.603,348.554,351.011,353.963,357.914,360.506,364.457,366.914,371.369,375.824,380.279,383.734,386.191,390.646,394.597,397.189,401.644,404.101,408.556,412.507,415.459,418.051,425.008,428.959,432.91,436.366,440.821,443.773,447.724,451.18,453.772,457.723,461.179,463.771,468.226,472.177,475.129,477.586,480.178,484.633,487.585,490.177,492.634,497.089,501.04,503.47,508.609,511.561,515.512,517.969,521.92,525.871,528.328,532.783,535.735,538.192,542.143,545.644" svgx:width="0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.5,0.44,0.28,0.33,0.44,0.25,0.44,0.28,0.5,0.5,0.5,0.39,0.28,0.5,0.44,0.25,0.5,0.28,0.5,0.44,0.33,0.25,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.39,0.25,0.44,0.39,0.25,0.5,0.44,0.33,0.28,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.61,0.33,0.44,0.28,0.44,0.44,0.28,0.5,0.33,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">questionnaire alongside other measures as part of the Trajectories </text>
   <text y="154.089" x="310.007,314.462,317.414,319.664,320.654,327.107,331.562,334.019,337.97,342.425,349.382,353.333,356.789,359.039,360.029,362.486,366.941,369.191,370.181,376.634,380.585,385.04,387.992,392.447,394.904,399.358,403.813,406.27,410.221,414.172,416.629,418.879,419.869,425.827,430.282,434.737,439.192,441.649,444.106,446.563,451.018,455.473,458.929,461.179,462.169,465.121,470.413,476.866,483.319,485.776,491.734,494.686,496.936,497.926,500.878,504.829,508.285,512.236,516.187,519.139,523.09,527.545,529.795,530.785,535.24,538.192,542.647" svgx:width="0.5,0.33,0.25,0.55,0.72,0.5,0.28,0.44,0.5,0.78,0.44,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.72,0.44,0.5,0.33,0.5,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.67,0.5,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.33,0.61,0.72,0.72,0.28,0.67,0.33,0.25,0.55,0.33,0.44,0.39,0.44,0.44,0.33,0.44,0.5,0.25,0.55,0.5,0.33,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of Outcomes in Neurological Conditions (TONiC) research pro-</text>
   <text y="165.087" x="310.007,314.462,317.414,321.365,328.322,335.279,339.23,341.435,344.171,349.625,354.08,358.031,360.929,365.384,369.839,373.79,377.246,379.703,382.16,386.615,391.07,395.525,399.476,401.933,404.885,408.836,411.734,418.187,422.138,425.594,428.492,431.444,435.395,437.852,442.306,445.258,449.713,453.664,458.119,461.017,465.472,469.927,472.825,477.28,481.735,486.19,489.088,493.543,497.494,499.951,502.408,506.359,510.814,513.271,516.727,519.625,522.577,527.032,531.487,533.692,538.147,545.644" svgx:width="0.5,0.33,0.44,0.78,0.78,0.44,0.25,0.25,0.61,0.5,0.44,0.25,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.5,0.44,0.28,0.33,0.44,0.25,0.72,0.44,0.39,0.25,0.33,0.44,0.28,0.5,0.33,0.5,0.44,0.5,0.25,0.5,0.5,0.25,0.5,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.5,0.5,0.25,0.5,0.83,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">gramme. The questionnaire was returned by 260 patients (68.4% </text>
   <text y="176.085" x="310.007,312.959,316.91,320.366,324.821,329.276,333.731,337.187,341.138,344.09" svgx:width="0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">response).</text>
   <text y="187.083" x="322.004,328.502,332.498,335.0,338.996,340.868,343.865,346.862,351.362,358.364,360.236,364.232,368.228,372.224,376.724,378.596,383.096,386.093,387.965,390.467,394.967,398.963,400.835,404.336,408.332,412.832,416.828,421.328,423.038,431.534,438.032,444.53,451.028,457.526,462.53,465.527,468.524,471.521,473.393,476.894,481.394,485.894,489.395,493.391,497.387,499.889,503.885,507.386,509.258,515.756,519.752,522.749,526.745,528.617,531.119,535.619,540.119,542.621" svgx:width="0.72,0.44,0.28,0.44,0.25,0.33,0.33,0.5,0.78,0.25,0.44,0.44,0.44,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.39,0.44,0.5,0.44,0.5,0.25,0.94,0.72,0.72,0.72,0.72,0.56,0.33,0.33,0.33,0.25,0.39,0.5,0.5,0.39,0.44,0.44,0.28,0.44,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.28,0.5,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Data from each of the seven WHODAS-II subscales were indi-</text>
   <text y="198.081" x="310.007,314.507,317.009,321.509,326.009,330.005,332.507,335.009,339.509,341.759,342.686,346.682,351.182,355.682,358.184,360.686,364.682,369.182,371.432,372.359,374.861,379.361,381.611,382.538,385.04,389.54,393.536,395.786,396.713,401.213,405.713,408.215,412.715,415.217,419.717,426.719,431.219,435.719,439.22,441.47,442.397,447.401,451.397,454.394,456.896,459.398,463.394,465.896,468.146,469.073,475.076,478.073,482.069,486.569,489.071,491.573,493.823,494.75,500.753,504.749,508.25,512.246,516.746,518.996,519.923,527.924,532.424,536.924,540.92,543.422,545.672" svgx:width="0.5,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.28,0.5,0.28,0.5,0.78,0.5,0.5,0.39,0.25,0.55,0.56,0.44,0.33,0.28,0.28,0.44,0.28,0.25,0.55,0.67,0.33,0.44,0.5,0.28,0.28,0.25,0.55,0.67,0.44,0.39,0.44,0.5,0.25,0.55,0.89,0.5,0.5,0.44,0.28,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">vidually applied to the polytomous Partial Credit Rasch Model. </text>
   <text y="209.079" x="310.007,315.011,317.513,320.015,322.265,323.444,325.946,330.446,332.696,333.875,336.377,340.877,344.873,347.123,348.302,354.305,358.301,361.802,365.798,370.298,372.548,373.727,380.729,385.229,389.729,393.725,396.227,398.477,399.656,406.154,410.15,413.651,415.901,417.08,421.076,424.577,428.078,432.074,435.575,439.076,443.072,447.572,449.822,451.001,455.501,459.002,461.504,466.004,470.504,472.754,473.933,476.435,480.935,484.931,487.181,488.36,492.356,496.856,499.358,502.355,505.856,510.356,514.856,518.852,521.849,525.845,528.095,529.274,532.271,536.267" svgx:width="0.56,0.28,0.28,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.67,0.44,0.39,0.44,0.5,0.25,0.55,0.78,0.5,0.5,0.44,0.28,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.44,0.39,0.39,0.44,0.39,0.39,0.44,0.5,0.25,0.55,0.5,0.39,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.28,0.33,0.39,0.5,0.5,0.44,0.33,0.44,0.25,0.55,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Fit to the Rasch model was assessed using the chi-square (χ </text>
   <text y="206.583" x="539.747" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="209.103" x="542.672,545.669" svgx:width="0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">) </text>
   <text y="220.101" x="310.013,313.514,316.016,320.012,322.514,325.016,328.517,331.02,333.522,337.518,339.768,342.018,343.647,350.145,352.647,357.147,361.143,364.14,366.39,368.019,372.519,376.02,380.52,384.516,389.016,393.516,400.518,404.514,407.016,410.013,412.515,416.511,418.761,420.39,424.386,427.383,429.885,432.387,436.383,439.38,441.882,445.878,448.128,449.757,452.259,456.759,460.755,463.257,467.757,472.257,474.759,479.259,483.759,486.009,487.638,490.635,494.631,497.133,499.635,503.631,508.131,510.633,513.135,515.637,518.139,522.054,524.304,526.554,528.183,530.685,535.185,539.181,543.177,545.679" svgx:width="0.39,0.28,0.44,0.28,0.28,0.39,0.28,0.28,0.44,0.25,0.25,0.55,0.72,0.28,0.5,0.44,0.33,0.25,0.55,0.5,0.39,0.5,0.44,0.5,0.5,0.78,0.44,0.28,0.33,0.28,0.44,0.25,0.55,0.44,0.33,0.28,0.28,0.44,0.33,0.28,0.44,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.33,0.44,0.28,0.28,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.25,0.55,0.28,0.5,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">statistic. Other psychometric criteria including reliability, local </text>
   <text y="231.099" x="310.013,314.513,318.509,323.009,327.005,331.505,336.005,340.001,344.501,348.497,352.412,354.662,356.57,361.07,363.572,366.407,369.404,373.4,376.397,380.393,384.893,387.396,389.898,393.894,396.396,398.304,400.806,403.308,407.304,414.306,416.214,419.211,423.711,428.211,432.207,434.709,437.211,441.711,446.211,448.713,453.213,457.713,459.963,461.871,466.371,468.873,475.875,479.871,484.371,487.872,490.374,494.874,499.374,503.37,505.872,508.374,510.876,515.376,517.284,521.28,525.78,530.28,532.188,536.184,540.18,542.682" svgx:width="0.5,0.44,0.5,0.44,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.28,0.28,0.44,0.78,0.25,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.25,0.5,0.28,0.78,0.44,0.5,0.39,0.28,0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.25,0.44,0.5,0.5,0.25,0.44,0.44,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">dependency, differential item functioning, dimensionality and cat-</text>
   <text y="242.097" x="310.013,314.009,318.509,323.009,326.006,330.506,332.576,335.078,339.578,342.575,346.571,350.072,354.572,359.072,361.574,366.074,368.145,372.141,376.641,380.637,383.139,387.639,391.14,393.642,397.143,399.393,401.301,406.8,411.3,415.296,417.366,421.866,424.368,427.365,430.362,434.358,438.354,440.856,445.356,448.353,450.423,457.425,461.925,466.425,470.421,472.923,474.993,481.491,485.487,488.988,491.058,495.558,499.059,503.055,507.555,509.625,512.127,516.627,518.697,521.199,525.699,530.199,534.195,537.696,540.198,542.7" svgx:width="0.44,0.5,0.5,0.33,0.5,0.25,0.28,0.5,0.33,0.44,0.39,0.5,0.5,0.28,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.25,0.61,0.5,0.44,0.25,0.5,0.28,0.33,0.33,0.44,0.44,0.28,0.5,0.33,0.25,0.78,0.5,0.5,0.44,0.28,0.25,0.72,0.44,0.39,0.25,0.5,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.5,0.44,0.39,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">egory threshold analysis. The bi-factor model was used to investi-</text>
   <text y="253.095" x="310.013,314.513,318.509,321.011,325.007,327.257,329.759,334.259,338.255,340.505,345.005,348.002,351.998,355.499,359.495,363.995,367.991,371.987,374.237,378.737,381.734,383.984,387.98,390.23,394.73,399.23,401.733,406.233,408.735,415.737,419.733,424.233,427.734,430.236,434.736,439.236,443.232,445.734,447.984,452.484,454.986,459.486,463.986,467.982,470.799,473.796,478.296,481.293,485.793,489.789,492.786,495.036,498.033,502.029,506.025,508.527,513.027,515.529" svgx:width="0.5,0.44,0.28,0.44,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.44,0.44,0.25,0.5,0.33,0.25,0.44,0.25,0.5,0.5,0.28,0.5,0.28,0.78,0.44,0.5,0.39,0.28,0.5,0.5,0.44,0.28,0.25,0.5,0.28,0.5,0.5,0.44,0.33,0.33,0.5,0.33,0.5,0.44,0.33,0.25,0.33,0.44,0.44,0.28,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">gate the presence of a unidimensional higher-order factor.</text>
   <text y="264.093" x="310.013,316.511,320.507,324.008,329.012,331.514,334.511,338.012,341.009" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="264.093" x="348.317,354.32,358.316,361.817,365.813,370.313,372.563,377.621,381.617,386.117,390.113,392.615,397.115,400.616,403.118,406.62,408.87,413.928,417.924,422.424,426.924,429.921,432.423,435.42,442.422,446.418,450.918,453.168,458.226,460.728,465.228,469.224,471.474,476.532,480.033,484.533,487.035,489.537,493.533,498.033,500.535,503.037,505.539,508.041,512.541,514.791,519.849,524.349,527.346,529.596,534.654,537.156,541.656,545.652" svgx:width="0.67,0.44,0.39,0.44,0.5,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.33,0.28,0.33,0.78,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.5,0.28,0.28,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Rasch analysis confirmed the suitability of the </text>
   <text y="275.091" x="310.013,313.01,319.013,323.513,328.013,332.513,335.015,337.517,340.019,344.519,349.019,351.35,353.6,355.139" svgx:width="0.33,0.67,0.5,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.33,0.25,0.55,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">‘Cognition’ (</text>
   <text y="275.091" x="358.137" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">p</text>
   <text y="275.091" x="362.637,367.712,372.212,374.462,378.962,383.462,386.46,388.71,390.96,392.499,395.496,403.497,407.997,412.497,414.999,417.501,420.003,422.505,427.005,429.336,431.586,433.125" svgx:width="0.56,0.5,0.25,0.5,0.5,0.33,0.25,0.25,0.55,0.33,0.89,0.5,0.5,0.28,0.28,0.28,0.28,0.5,0.33,0.25,0.55,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">=0.29), ‘Mobility’ (</text>
   <text y="275.091" x="436.122" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">p</text>
   <text y="275.091" x="440.622,445.698,450.198,452.448,456.948,461.448,464.445,466.695,468.945,470.484,473.481,478.485,482.481,484.983,487.98,490.977,494.973,498.969,501.966,505.962,508.293,510.543,512.082" svgx:width="0.56,0.5,0.25,0.5,0.5,0.33,0.25,0.25,0.55,0.33,0.56,0.44,0.28,0.33,0.33,0.44,0.44,0.33,0.44,0.33,0.25,0.55,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">=0.24), ‘Self-care’ (</text>
   <text y="275.091" x="515.079" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">p</text>
   <text y="275.091" x="519.579,524.655,529.155,531.405,535.905,540.405,543.402,545.652" svgx:width="0.56,0.5,0.25,0.5,0.5,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">=0.26), </text>
   <text y="286.089" x="310.013,313.01,318.509,321.011,324.008,328.004,330.254,331.127,335.123,339.119,341.621,344.123,348.623,351.125,353.628,356.13,360.126,363.627,365.958,368.208,369.081" svgx:width="0.33,0.61,0.28,0.33,0.44,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.28,0.44,0.39,0.33,0.25,0.55,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">‘Life activities’ (</text>
   <text y="286.089" x="372.078" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">p</text>
   <text y="286.089" x="376.578,381.654,386.154,388.404,392.904,397.404,400.401,402.651,403.524,407.52,412.02,416.52,418.77,419.643,422.64,427.644,431.64,434.637,437.139,439.641,443.637,446.139,450.639,454.635,457.137,459.639,464.139,468.639,470.97,473.22,474.093" svgx:width="0.56,0.5,0.25,0.5,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.56,0.44,0.33,0.28,0.28,0.44,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.33,0.25,0.55,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">=0.66) and ‘Participation’ (</text>
   <text y="286.089" x="477.09" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">p</text>
   <text y="286.089" x="481.59,486.666,488.916,489.789,494.289,496.539,501.039,505.539,508.536,510.786,511.659,515.16,519.66,524.16,527.661,531.657,535.653,538.155,542.151,545.651" svgx:width="0.56,0.25,0.55,0.5,0.25,0.5,0.5,0.33,0.25,0.55,0.39,0.5,0.5,0.39,0.44,0.44,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">= 0.84) subscales </text>
   <text y="297.087" x="310.013,313.01,317.51,320.507,322.757,323.873,328.373,331.874,335.87,338.12,339.236,341.738,346.238,348.488,349.604,352.106,356.606,359.108,362.609,364.859,365.975,370.475,374.975,379.475,383.975,386.478,390.474,392.976,395.478,399.978,404.478,406.728,407.844,414.342,416.844,419.346,423.846,428.346,432.846,435.348,437.598,438.714,445.716,450.216,454.716,457.218,460.215,462.717,466.713,470.709,473.211,475.713,480.213,484.713,486.963,489.213,490.32,496.323,500.319,502.821,505.323,509.319,513.819,516.321,518.823,521.325,523.827,528.327,530.577,531.693,538.191,542.187,545.688" svgx:width="0.33,0.5,0.33,0.25,0.55,0.5,0.39,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.28,0.39,0.25,0.55,0.5,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.5,0.5,0.28,0.25,0.55,0.78,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.67,0.44,0.28,0.28,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.72,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">for use in this population without modification. Reliability was </text>
   <text y="308.085" x="310.013,314.009,318.005,322.001,325.997,330.497,332.999,336.995,341.495,343.997,347.993,350.243,351.251,354.248,358.748,361.745,363.995,365.003,367.505,372.005,376.001,379.503,383.499,385.749,386.757,390.258,394.758,399.258,402.759,406.755,410.751,413.253,417.249,420.75,423.0,424.008,427.005,432.009,437.013,440.01,442.26,443.268,448.344,450.594,451.602,456.102,458.352,462.852,467.352,470.349,474.849,477.099,481.599,486.099,489.096,491.346,493.596,494.442,499.941,504.441,508.437,510.687,511.695,515.196,519.696,524.196,527.697,531.693,535.688,538.19,542.186,545.687" svgx:width="0.44,0.44,0.44,0.44,0.5,0.28,0.44,0.5,0.28,0.44,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.39,0.44,0.25,0.55,0.39,0.5,0.5,0.39,0.44,0.44,0.28,0.44,0.39,0.25,0.55,0.33,0.56,0.56,0.33,0.25,0.55,0.56,0.25,0.55,0.5,0.25,0.5,0.5,0.33,0.5,0.25,0.5,0.5,0.33,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.39,0.5,0.5,0.39,0.44,0.44,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">acceptable for these subscales (PSI = 0.76-0.91). The subscales </text>
   <text y="319.083" x="310.013,316.511,320.507,323.504,327.5,329.489,332.486,335.483,339.479,343.475,345.464,348.461,351.458,355.958,362.961,364.95,367.452,371.952,375.948,379.944,382.446,384.435,388.935,392.931,397.431,401.427,405.927,410.427,414.423,418.923,422.919,427.419,429.408,433.404,437.904,442.404,444.393,448.893,451.395,454.23,457.227,461.223,464.22,468.216,472.716,475.218,477.72,481.716,484.218,486.207,488.709,491.211,495.207,502.209,504.198,507.195,511.695,516.195,520.191,522.693,525.195,529.695,534.195,536.697,541.197,545.697" svgx:width="0.72,0.44,0.33,0.44,0.25,0.33,0.33,0.44,0.44,0.25,0.33,0.33,0.5,0.78,0.25,0.28,0.5,0.44,0.44,0.28,0.25,0.5,0.44,0.5,0.44,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.28,0.28,0.44,0.78,0.25,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were free from local dependency and differential item functioning </text>
   <text y="330.081" x="310.013,314.009,318.509,323.009,325.259,331.757,335.753,338.75,342.746,344.996,349.496,353.996,356.498,360.998,363.5,370.502,374.498,378.998,382.499,385.001,389.501,394.001,397.997,400.5" svgx:width="0.44,0.5,0.5,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.5,0.28,0.5,0.28,0.78,0.44,0.5,0.39,0.28,0.5,0.5,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and were unidimensional.</text>
   <text y="341.079" x="322.01,327.509,332.009,336.005,338.264,341.261,347.759,351.755,354.257,356.759,359.261,363.761,368.261,370.52,374.516,377.018,381.518,386.018,390.518,392.85,395.109,398.61,403.11,407.61,411.111,415.107,419.103,421.605,425.601,427.86,432.36,434.862,439.362,441.621,446.121,450.621,453.123,455.382,458.379,460.881,463.383,465.642,468.144,472.644,476.64,478.899,484.902,488.898,492.399,496.395,500.895,503.154,510.156,514.656,519.156,523.152,525.654,527.913,530.415,534.915,537.174,539.676,542.178,545.679" svgx:width="0.61,0.5,0.44,0.25,0.33,0.72,0.44,0.28,0.28,0.28,0.5,0.5,0.25,0.44,0.28,0.5,0.5,0.5,0.33,0.25,0.39,0.5,0.5,0.39,0.44,0.44,0.28,0.44,0.25,0.5,0.28,0.5,0.25,0.5,0.5,0.28,0.25,0.33,0.28,0.28,0.25,0.28,0.5,0.44,0.25,0.67,0.44,0.39,0.44,0.5,0.25,0.78,0.5,0.5,0.44,0.28,0.25,0.28,0.5,0.25,0.28,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The ‘Getting along’ subscale did not fit the Rasch model in its </text>
   <text y="352.077" x="310.013,314.513,317.51,320.012,324.512,327.014,331.514,335.51,338.012,339.677,342.674,347.174,350.172,357.174,358.839" svgx:width="0.5,0.33,0.28,0.5,0.28,0.5,0.44,0.28,0.25,0.33,0.5,0.33,0.78,0.25,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">original form (</text>
   <text y="352.077" x="361.836" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">p</text>
   <text y="352.077" x="366.336,371.412,373.077,377.577,379.827,384.327,388.827,393.327,396.324,398.574,400.239,408.24,410.742,414.243,417.24,419.742,422.244,423.909,430.407,434.403,437.904,439.569,444.069,447.066,449.568,454.068,458.064,462.564,464.229,468.729,473.229,474.894,477.396,481.896,485.892,487.557,490.059,492.561,496.557,503.559,505.224,509.724,511.974,516.474,518.139,521.136,526.14,530.136,534.636,539.136,543.132,545.634" svgx:width="0.56,0.25,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.25,0.89,0.28,0.39,0.33,0.28,0.28,0.25,0.72,0.44,0.39,0.25,0.5,0.33,0.28,0.5,0.44,0.5,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.28,0.44,0.78,0.25,0.5,0.25,0.5,0.25,0.33,0.56,0.44,0.5,0.5,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">&lt; 0.001). Misfit was driven by the item 4.5 ‘Sexual </text>
   <text y="363.075" x="310.013,314.009,318.005,320.507,323.009,327.509,330.011,332.513,335.016,339.012,342.513,345.51,347.76,349.92,357.921,362.421,366.921,370.917,373.419,375.579,378.576,381.078,383.58,385.74,389.736,394.236,398.736,400.896,405.396,407.898,412.398,416.394,419.391,421.551,425.547,428.544,431.046,433.548,437.544,440.541,443.043,447.039,449.199,455.697,459.693,462.69,466.686,468.846,473.346,476.343,480.339,484.335,486.837,489.339,493.839,495.999,498.501,505.503,510.003,513.0,517.5,522.0,525.996,530.496,532.656,535.653,540.153,542.655" svgx:width="0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.28,0.44,0.39,0.33,0.25,0.25,0.89,0.5,0.5,0.44,0.28,0.25,0.33,0.28,0.28,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.5,0.44,0.33,0.25,0.44,0.33,0.28,0.28,0.44,0.33,0.28,0.44,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.25,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.5,0.25,0.33,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">activities’. Model fit and other criteria were greatly improved fol-</text>
   <text y="374.073" x="310.013,312.515,317.015,323.513,326.015,330.515,335.015,337.265,339.767,344.267,348.263,350.513,353.51,357.506,364.508,369.008,373.508,377.504,380.007,382.257,386.757,389.754,392.004,394.506,397.008,401.004,408.006,410.256,414.756,417.006,421.506,423.756" svgx:width="0.28,0.5,0.72,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.33,0.44,0.78,0.5,0.5,0.44,0.28,0.25,0.5,0.33,0.25,0.28,0.28,0.44,0.78,0.25,0.5,0.25,0.5,0.25,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">lowing the removal of item 4.5 (</text>
   <text y="374.073" x="426.753" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">p</text>
   <text y="374.073" x="431.253,436.329,440.829,443.079,447.579,452.079,455.076" svgx:width="0.56,0.5,0.25,0.5,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">=0.18).</text>
   <text y="385.071" x="322.01,327.509,332.009,336.005,338.426,342.926,345.428,348.425,351.422,355.418,359.414,361.916,366.416,369.413,371.834,378.836,383.336,387.836,391.832,394.335,396.755,403.253,407.249,410.75,413.171,417.671,422.171,426.167,430.667,433.169,437.165,439.586,442.089,446.589,449.009,453.005,457.505,462.005,465.003,467.505,470.502,477.504,479.925,482.427,486.927,490.923,493.344,496.845,501.345,503.847,506.349,510.345,514.845,517.347,519.849,522.351,524.853,529.353,531.774,536.274,539.271,541.692,545.688" svgx:width="0.61,0.5,0.44,0.25,0.5,0.28,0.33,0.33,0.44,0.44,0.28,0.5,0.33,0.25,0.78,0.5,0.5,0.44,0.28,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.44,0.5,0.28,0.44,0.25,0.28,0.5,0.25,0.44,0.5,0.5,0.33,0.28,0.33,0.78,0.25,0.28,0.5,0.44,0.25,0.39,0.5,0.28,0.28,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The bi-factor model was unable to confirm the suitability of a </text>
   <text y="396.069" x="310.013,313.514,316.016,320.516,325.016,327.518,331.514,333.764,335.357,339.857,344.357,346.859,351.359,353.861,360.863,364.859,369.359,372.861,375.363,379.863,384.363,388.359,390.861,393.111,394.704,399.204,401.706,406.206,410.706,414.702,417.519,420.516,425.016,428.013,432.513,436.509,439.506,441.756,443.349,446.346,450.342,454.338,456.84,461.34,464.337,466.587,468.18,471.177,475.677,478.674,480.924,482.517,485.019,489.519,493.515,495.765,497.196,505.692,512.19,518.688,525.186,531.684,536.688,539.685,542.682,545.679" svgx:width="0.39,0.28,0.5,0.5,0.28,0.44,0.25,0.55,0.5,0.5,0.28,0.5,0.28,0.78,0.44,0.5,0.39,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.5,0.28,0.5,0.5,0.44,0.33,0.33,0.5,0.33,0.5,0.44,0.33,0.25,0.55,0.33,0.44,0.44,0.28,0.5,0.33,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.94,0.72,0.72,0.72,0.72,0.56,0.33,0.33,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">single unidimensional higher-order factor for the WHODAS-II </text>
   <text y="407.067" x="310.013" svgx:width="0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(</text>
   <text y="407.067" x="313.01" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">p</text>
   <text y="407.067" x="317.51,322.586,324.836,329.336,331.586,336.086,340.586,345.086,348.083" svgx:width="0.56,0.25,0.5,0.25,0.5,0.5,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">&lt; 0.001).</text>
   <text y="418.065" x="310.013,316.466,320.921,325.88,329.831,332.288,337.247,340.703,343.16,347.615,352.574,356.03,358.982" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="418.065" x="360.962,366.416,370.871,374.822,376.64,385.091,391.544,397.997,404.45,410.903,415.862,418.814,421.766,424.718,426.698,431.153,435.104,438.56,440.54,444.995,449.45,453.905,458.36,460.34,464.795,468.251,472.706,476.657,481.112,485.567,492.524,496.475,498.932,501.884,504.341,508.292,510.272,514.223,518.678,522.629,525.581,529.532,533.483,535.94,539.891,542.672" svgx:width="0.61,0.5,0.44,0.25,0.94,0.72,0.72,0.72,0.72,0.56,0.33,0.33,0.33,0.25,0.5,0.44,0.39,0.25,0.5,0.5,0.5,0.5,0.25,0.5,0.39,0.5,0.44,0.5,0.5,0.78,0.44,0.28,0.33,0.28,0.44,0.25,0.44,0.5,0.44,0.33,0.44,0.44,0.28,0.44,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The WHODAS-II has good psychometric character-</text>
   <text y="429.063" x="310.013,312.47,315.926,318.383,320.84,324.791,328.247,330.11,336.563,341.018,344.969,349.424,351.287,355.238,359.693,366.65,371.105,373.562,377.513,379.97,383.921,388.376,390.239,394.694,399.149,401.012,405.467,409.418,411.875,414.332,418.283,422.738,425.195,428.651,430.514,436.967,439.424,441.881,446.336,448.199,456.155,461.114,463.319,465.182,468.134,470.591,474.542,481.499,483.362,487.817,490.022,494.477,496.34,499.292,504.251,508.202,512.657,517.112,521.063,523.52,525.383,529.334,533.285,535.742,538.199,542.654" svgx:width="0.28,0.39,0.28,0.28,0.44,0.39,0.25,0.72,0.5,0.44,0.5,0.25,0.44,0.5,0.78,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.89,0.56,0.25,0.25,0.33,0.28,0.44,0.78,0.25,0.5,0.25,0.5,0.25,0.33,0.56,0.44,0.5,0.5,0.44,0.28,0.25,0.44,0.44,0.28,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">istics when completed by patients with MS. Item 4.5 ‘Sexual activ-</text>
   <text y="440.061" x="310.013,312.47,314.927,317.384,321.335,324.791,327.077,329.633,333.584,337.535,341.99,345.446,349.397,353.852,356.408,363.365,365.822,369.278,372.23,374.687,377.144,379.7,382.652,387.107,390.059,392.615,395.072,399.527,403.478,406.034,408.986,415.439,419.39,421.847,424.304,426.761,431.216,435.671,438.227,442.178,444.635,449.09,453.545,458.0,460.286,462.842,466.298,470.753,475.208,478.664,482.615,486.566,489.023,492.974,495.53,499.481,503.936,508.391,510.947,514.403,518.858,523.313,527.768,530.225,534.68,537.236,541.691,545.687" svgx:width="0.28,0.28,0.28,0.44,0.39,0.33,0.25,0.44,0.44,0.5,0.39,0.44,0.5,0.25,0.78,0.28,0.39,0.33,0.28,0.28,0.25,0.33,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.33,0.72,0.44,0.28,0.28,0.28,0.5,0.5,0.25,0.44,0.28,0.5,0.5,0.5,0.33,0.25,0.39,0.5,0.5,0.39,0.44,0.44,0.28,0.44,0.25,0.44,0.5,0.5,0.25,0.39,0.5,0.5,0.5,0.28,0.5,0.25,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ities’ caused misfit for the ‘Getting along’ subscale and should be </text>
   <text y="451.059" x="310.013,312.965,316.916,323.873,328.328,332.783,336.734,341.189,342.989,345.446,349.901,351.701,355.652,360.107,363.563,368.018,370.97,374.921,376.721,380.672,384.623,388.574,393.029,395.981,399.932,402.389,406.34,408.14,415.097,419.048,422.999,426.455,430.91,433.862,437.813,444.77,448.721,453.176,455.633,457.433,461.888,464.84,466.64,471.095,473.552,477.008,480.959,485.414,487.871,490.328,492.785,495.242,499.697,501.497,503.954,508.409,510.209,512.666,517.121,519.578,523.034,524.834,529.289,533.744,538.199,542.654" svgx:width="0.33,0.44,0.78,0.5,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.44,0.5,0.39,0.5,0.33,0.44,0.25,0.44,0.44,0.44,0.5,0.33,0.44,0.28,0.44,0.25,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.25,0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.28,0.39,0.25,0.5,0.5,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">removed to ensure accurate measurement of disability in this popu-</text>
   <text y="462.057" x="310.013,312.47,316.421,318.878,321.335,325.79,330.245,332.45,334.502,339.956,344.411,348.362,351.314,355.265,357.479,363.932,367.883,371.339,373.553,378.008,382.463,384.677,388.628,393.083,395.54,399.995,403.946,408.401,412.352,416.303,418.517,420.974,425.429,427.643,431.099,435.554,440.009,444.464,448.919,451.871,454.328,456.542,458.999,463.454,467.405,469.619,474.074,477.53,481.481,483.695,488.15,491.102,493.316,495.773,500.228,502.685,506.636,509.093,511.307,514.763,518.714,523.169,526.121,530.072,532.286,534.743,539.198,543.149,545.651" svgx:width="0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.61,0.5,0.44,0.33,0.44,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.25,0.44,0.5,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.28,0.5,0.25,0.39,0.5,0.5,0.5,0.5,0.33,0.28,0.25,0.28,0.5,0.44,0.25,0.5,0.39,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.28,0.44,0.28,0.25,0.39,0.44,0.5,0.33,0.44,0.25,0.28,0.5,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">lation. There was no evidence to support the use of total score that </text>
   <text y="473.055" x="310.013,313.964,318.419,325.376,329.831,332.288,336.743,340.694,345.149,347.354,349.811,352.268,356.219,363.176,366.632,368.837,371.789,374.741,379.196,386.153,388.358,392.309,394.766,397.223,399.428,403.883,406.835,409.04,411.497,415.952,419.903,422.108,425.564,429.515,433.97,437.921,442.376,444.581,449.036,453.491,460.448,464.399,466.856,471.311,474.767,476.81,485.261,491.714,498.167,504.62,511.073,516.032,518.984,521.936,524.888" svgx:width="0.44,0.5,0.78,0.5,0.28,0.5,0.44,0.5,0.25,0.28,0.28,0.44,0.78,0.39,0.25,0.33,0.33,0.5,0.78,0.25,0.44,0.28,0.28,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.39,0.44,0.5,0.44,0.5,0.25,0.5,0.5,0.78,0.44,0.28,0.5,0.39,0.25,0.94,0.72,0.72,0.72,0.72,0.56,0.33,0.33,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">combined items from all of the seven domains WHODAS-II.</text>
   <text y="495.051" x="310.013,315.512,320.012,324.512" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P799</text>
   <text y="506.049" x="310.013,313.514,321.011,326.015,330.515,334.511,337.508,339.758,344.258,347.255,349.505,352.502,356.498,360.494,364.994,367.991,375.488,379.484,384.488,387.486,390.483,394.479,398.475,400.977,405.477,408.474,412.47,417.474,419.724,422.721,425.223,430.227,433.224,435.726,438.228,443.232,447.228,449.478,452.979,457.479,464.976,469.98,472.977,477.477,484.974,488.475,490.725,495.225,500.229,505.233" svgx:width="0.39,0.83,0.56,0.5,0.44,0.33,0.25,0.5,0.33,0.25,0.33,0.44,0.44,0.5,0.33,0.83,0.44,0.56,0.33,0.33,0.44,0.44,0.28,0.5,0.33,0.44,0.56,0.25,0.33,0.28,0.56,0.33,0.28,0.28,0.56,0.44,0.25,0.39,0.5,0.83,0.56,0.33,0.5,0.83,0.39,0.25,0.5,0.56,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Impact of treatment-related flu-like symptoms and </text>
   <text y="517.047" x="310.013,312.515,317.519,320.516,324.512,328.508,331.505,334.007,338.507,343.511,345.761,349.262,351.764,354.762,358.758,361.008,365.004,369.0,373.5,377.496,380.493,382.995,387.495,392.499,396.0,398.25,402.75,407.754,410.004,415.008,420.012,424.512,427.014,429.516,432.513,437.013,439.263,443.763,446.76,449.01,451.512,454.014,457.011,461.007,463.257,465.759,470.763,473.013,478.017,482.517,485.514,488.016,492.012,497.016,500.013,503.514,505.764,512.262,514.764,517.761,522.765" svgx:width="0.28,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.56,0.25,0.39,0.28,0.33,0.44,0.25,0.44,0.44,0.5,0.44,0.33,0.28,0.5,0.56,0.39,0.25,0.5,0.56,0.25,0.56,0.56,0.5,0.28,0.28,0.33,0.5,0.25,0.5,0.33,0.25,0.28,0.28,0.33,0.44,0.25,0.28,0.56,0.25,0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.39,0.25,0.72,0.28,0.33,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">injection site reactions on quality of life in patients with </text>
   <text y="528.045" x="310.013,317.51,322.514,325.016,328.013,330.515,335.519,338.021,342.017,344.267,347.768,351.764,354.267,358.263,362.259,366.759,370.26,372.762,376.263,379.26,381.51,388.008,394.506,401.004,407.501,413.999,420.497,426.5,428.75,432.251,435.248,440.252,445.256" svgx:width="0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39,0.33,0.25,0.72,0.72,0.72,0.72,0.72,0.72,0.67,0.25,0.39,0.33,0.56,0.56,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">multiple sclerosis: ADVANCE study</text>
   <text y="539.043" x="310.013,315.512,321.011,323.261,329.759,332.261,336.761,339.263,343.259" svgx:width="0.61,0.61,0.25,0.72,0.28,0.5,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ET Kinter</text>
   <text y="536.583" x="346.258" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="539.103" x="349.183,351.433,353.683,358.687,360.937,367.435,371.935" svgx:width="0.25,0.25,0.56,0.25,0.72,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, S Guo</text>
   <text y="536.583" x="376.435" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="539.103" x="379.36,381.61,383.86,390.358,392.608,399.106,401.608,404.11,406.612,411.112,415.108,419.104,421.606,425.602" svgx:width="0.25,0.25,0.72,0.25,0.72,0.28,0.28,0.28,0.5,0.44,0.44,0.28,0.44,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Altincatal</text>
   <text y="536.583" x="428.103" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="539.103" x="431.029,433.279,435.529,438.526,440.776,445.78,448.777,453.277,456.778,461.278,465.778,468.775,473.275,477.775,481.276,485.776" svgx:width="0.25,0.25,0.33,0.25,0.56,0.33,0.5,0.39,0.5,0.5,0.33,0.5,0.5,0.39,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, I Proskorovsky</text>
   <text y="536.583" x="490.275" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="539.103" x="493.2,495.45,497.7,504.198" svgx:width="0.25,0.25,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, G </text>
   <text y="550.101" x="310.014,315.018,319.518,322.02,324.522,327.024,329.526,334.026" svgx:width="0.56,0.5,0.28,0.28,0.28,0.28,0.5,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Phillips</text>
   <text y="547.583" x="337.529" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="550.103" x="340.454,342.704,344.954,350.957,353.207,358.211,362.711,366.707,369.704,372.206,374.708,379.208" svgx:width="0.25,0.25,0.67,0.25,0.56,0.5,0.44,0.33,0.28,0.28,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, B Sperling</text>
   <text y="547.583" x="383.707" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="558.581" x="310.015" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="561.103" x="312.941,318.44,320.942,325.442,329.942,333.938,338.438,340.688,343.685,348.185,352.181,356.177,358.427,361.424,365.924,369.92,372.17,374.42,376.67,382.673,387.173,393.671,398.171,401.672,404.174,408.674,413.174,417.17,419.42,421.67,429.167,434.666,436.916,439.166,445.664,450.164,452.666,455.168,459.164,463.664,465.914,470.414,472.916,477.416,479.918,483.914,487.415,489.665" svgx:width="0.61,0.28,0.5,0.5,0.44,0.5,0.25,0.33,0.5,0.44,0.44,0.25,0.33,0.5,0.44,0.25,0.25,0.25,0.67,0.5,0.72,0.5,0.39,0.28,0.5,0.5,0.44,0.25,0.25,0.83,0.61,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Biogen Idec Inc., Cambridge, MA, United States, </text>
   <text y="558.583" x="491.913" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="561.103" x="494.838,500.337,504.333,506.835,511.335,515.331,518.832,523.332,525.582" svgx:width="0.61,0.44,0.28,0.5,0.44,0.39,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Evidera, </text>
   <text y="572.101" x="310.014,315.018,319.014,323.01,325.512,330.012,334.512,337.014,341.514,346.014,348.264,350.514,358.011,363.51,365.76,368.01,374.508,379.008,381.51,384.012,388.008,392.508,394.758,399.258,401.76,406.26,408.762,412.758,416.259,418.509" svgx:width="0.56,0.44,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.25,0.83,0.61,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Lexington, MA, United States, </text>
   <text y="569.583" x="420.76" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="572.103" x="423.685,429.184,433.18,435.682,440.182,444.178,447.679,452.179,454.429,456.679,464.176,468.676,473.176,475.678,479.179,483.175,487.675,490.177,492.427,494.677,501.175,507.178,509.428,511.678,517.681,522.181,526.681,531.181,535.681" svgx:width="0.61,0.44,0.28,0.5,0.44,0.39,0.5,0.25,0.25,0.83,0.5,0.5,0.28,0.39,0.44,0.5,0.28,0.25,0.25,0.72,0.67,0.25,0.25,0.67,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Evidera, Montreal, QC, Canada</text>
   <text y="599.103" x="310.015,316.018,320.518,324.514,329.518,334.018,337.852,342.352,347.356,352.36,357.364,360.361" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="599.103" x="363.691,368.695,371.197,375.697,378.694,381.196,383.698,388.198,392.194,394.444,395.524,399.025,403.525,410.527,415.027,417.529,422.029,429.031,432.532,434.782,435.862,438.859,443.863,449.362,454.366,457.363,459.613,460.693,464.689,469.189,473.689,475.939,477.019,479.521,484.021,486.523,490.519,494.515,497.017,499.519,504.019,508.519,510.769,511.849,515.35,517.852,520.354,524.35,526.6,527.68,530.677,534.673,538.669,542.665" svgx:width="0.56,0.28,0.5,0.33,0.28,0.28,0.5,0.44,0.25,0.55,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.39,0.25,0.55,0.33,0.56,0.61,0.56,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.39,0.28,0.28,0.44,0.25,0.55,0.33,0.44,0.44,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Flu-like symptoms (FLS) and injection site reac-</text>
   <text y="610.101" x="310.015,312.517,315.019,319.519,324.019,327.52,329.77,330.859,333.856,336.853,341.857,347.86,350.857,353.107,354.196,358.192,361.189,365.185,367.435,368.524,372.52,377.02,381.52,385.516,388.513,392.014,396.01,398.26,399.349,403.345,407.845,411.841,416.341,418.843,422.344,424.594,425.683,428.68,435.178,440.677,444.178,447.175,449.425,450.514,454.51,458.011,461.512,466.012,470.008,472.51,476.506,479.008,483.004,487.504,489.754,490.843,497.341,499.843,502.345,506.845,509.095,510.184,512.686,517.186,519.688,523.684,526.681,529.678,533.674,536.671,541.171,545.671" svgx:width="0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.33,0.33,0.56,0.67,0.33,0.25,0.55,0.44,0.33,0.44,0.25,0.55,0.44,0.5,0.5,0.44,0.33,0.39,0.44,0.25,0.55,0.44,0.5,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.72,0.61,0.39,0.33,0.25,0.55,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.28,0.44,0.33,0.33,0.44,0.33,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tions (ISR) are adverse events (AEs) associated with interferon </text>
   <text y="621.099" x="310.015,314.515,318.511,321.013,325.009,327.079,329.581,332.578,336.574,340.57,343.072,350.074,354.07,358.57,361.072,364.573,366.643,369.64,372.637,377.641,384.139,387.136,389.206,391.708,396.208,398.287,402.787,406.783,409.285,411.787,415.783,420.283,422.785,426.286,428.356,434.854,437.356,439.858,444.358,446.428,453.43,457.93,460.432,462.934,465.436,469.936,472.438,476.434,478.513,482.014,486.01,488.512,492.508,495.505,500.005,503.506,506.008,509.509,511.579,514.576,522.577,527.581,530.578,532.648,536.644,541.144,545.644" svgx:width="0.5,0.44,0.28,0.44,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.39,0.25,0.33,0.33,0.56,0.72,0.33,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.33,0.89,0.56,0.33,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">beta treatments (IFN) in patients with multiple sclerosis (MS) and </text>
   <text y="632.097" x="310.015,317.017,321.013,325.513,328.141,332.641,336.637,341.137,345.133,347.761,351.757,354.385,358.885,362.881,367.381,371.377,373.879,376.381,380.881,384.877,387.505,391.501,394.336,397.333,401.329,405.325,407.827,410.455,414.955,419.455,422.083,426.583,430.579,433.081,435.583,439.579,444.079,446.581,450.082,452.413,455.041,459.541,463.537,467.533,470.035,472.537,477.037,480.034,483.031,487.027,489.529,493.525,496.027,500.023,504.523,507.151,511.651,516.151,520.147,522.649,525.151,527.653,532.153,535.15,539.65,542.647" svgx:width="0.78,0.44,0.5,0.25,0.5,0.44,0.5,0.44,0.25,0.44,0.25,0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.44,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.33,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.33,0.33,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.5,0.5,0.44,0.28,0.28,0.28,0.5,0.33,0.5,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">may have a negative effect on patients’ health-related quality-of-</text>
   <text y="643.095" x="310.015,312.517,315.019,318.016,322.012,324.262,327.259,333.757,339.76,346.258,350.758,356.257,359.254" svgx:width="0.28,0.28,0.33,0.44,0.25,0.33,0.72,0.67,0.72,0.5,0.61,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">life (HRQoL).</text>
   <text y="654.093" x="310.015,317.017,322.021,325.018,329.014,333.01,336.007,338.509,343.009,347.005,350.506,353.503" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="654.093" x="357.265,362.134,366.634,368.884,370.396,374.392,377.893,381.394,385.39,388.891,392.392,394.642,396.154,398.656,403.156,407.152,409.402,410.914,413.416,420.418,424.918,428.914,432.91,435.412,437.662,439.174,443.674,446.671,448.921,450.433,455.437,460.936,465.94,468.19,469.702,473.698,478.198,482.698,484.948,486.46,489.457,494.461,500.464,502.714,504.226,508.726,513.226,515.476,516.988,523.486,529.489,535.987,540.487,545.653" svgx:width="0.61,0.5,0.25,0.55,0.44,0.39,0.39,0.44,0.39,0.39,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.78,0.5,0.44,0.44,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.56,0.61,0.56,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.56,0.67,0.25,0.55,0.5,0.5,0.25,0.55,0.72,0.67,0.72,0.5,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To assess the impact of FLS and ISR on HRQoL </text>
   <text y="665.091" x="310.015,314.515,318.016,320.518,325.018,329.518,331.768,336.268,340.264,342.766,346.762,349.012,352.009,355.006,359.506,366.508,368.758,371.26,375.76,379.756,382.006,386.506,391.006,395.002,398.503,402.499,404.749,409.249,411.004,417.502,424.0,429.337,435.835,442.333,448.336,453.835,456.085,459.586,462.088,466.588,471.088,475.003" svgx:width="0.5,0.39,0.28,0.5,0.5,0.25,0.5,0.44,0.28,0.44,0.25,0.33,0.33,0.5,0.78,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.44,0.39,0.44,0.25,0.5,0.25,0.72,0.72,0.72,0.72,0.72,0.67,0.61,0.25,0.39,0.28,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">using data from the phase 3 ADVANCE study.</text>
   <text y="676.089" x="310.015,318.646,322.777,325.909,331.048,335.683,340.822,344.458,347.59" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="676.089" x="351.514,358.147,364.78,370.252,376.885,383.518,389.656,395.29,397.675,399.925,401.599,405.73,407.98,409.654,412.786,416.917,421.552,426.187,430.822,437.959,440.596,444.727,448.858,453.493,455.878,458.128,459.802,464.437,469.072,473.707,478.342,480.979,485.11,488.242,492.877,495.514,498.151,502.786,507.421,509.806,512.056,513.73,518.365,521.002,525.133,529.264,533.395,538.03,542.665" svgx:width="0.72,0.72,0.72,0.72,0.72,0.67,0.61,0.25,0.25,0.55,0.44,0.25,0.55,0.33,0.44,0.5,0.5,0.5,0.78,0.28,0.44,0.44,0.5,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.28,0.44,0.33,0.5,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ADVANCE, a randomized, double-blind, placebo-</text>
   <text y="687.087" x="310.015,314.146,318.781,323.416,326.053,329.185,333.82,336.457,339.094,343.225,347.86,349.525,353.161,355.798,360.433,365.068,369.118,371.503,373.177,377.308,380.944,384.58,388.711,392.347,395.983,400.114,404.749,406.423,409.06,413.695,417.826,419.5,423.631,426.601,429.733,432.37,436.501,440.632,444.763,449.398,451.072,455.707,458.839,460.504,464.14,468.775,473.41,477.541,482.176,484.813,488.944,493.579,497.71,502.345,506.98,510.616,512.29,516.925,521.056,525.691,528.328,532.963,535.6,539.731,542.674" svgx:width="0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.28,0.44,0.5,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.44,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.33,0.33,0.28,0.44,0.44,0.44,0.5,0.25,0.5,0.33,0.25,0.39,0.5,0.5,0.44,0.5,0.28,0.44,0.5,0.44,0.5,0.5,0.39,0.25,0.5,0.44,0.5,0.28,0.5,0.28,0.44,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">controlled study, assessed the efficacy of subcutaneous peginter-</text>
   <text y="698.085" x="310.015,313.147,317.278,320.41,325.045,329.68,331.93,333.865,338.5,342.631,345.268,349.399,352.531,357.166,361.297,363.547,365.482,368.614,373.753,379.387,386.02,389.152,392.284,397.423,404.056,407.188,409.438,411.373,416.008,420.643,425.278,427.528,429.463,434.422,439.057,441.307,443.242,447.373,452.008,459.145,461.782,466.417,469.054,472.69,475.327,479.458,482.59,486.721,491.356,493.606,495.541,499.672,504.307,508.438,511.57,516.205,518.455,520.39,525.025,527.275,529.21,533.845,536.977,539.227,541.162,545.662" svgx:width="0.33,0.44,0.33,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.33,0.5,0.44,0.25,0.55,0.33,0.56,0.61,0.72,0.33,0.33,0.56,0.72,0.33,0.25,0.55,0.5,0.5,0.5,0.25,0.55,0.54,0.5,0.25,0.55,0.44,0.5,0.78,0.28,0.5,0.28,0.39,0.28,0.44,0.33,0.44,0.5,0.25,0.55,0.44,0.5,0.44,0.33,0.5,0.25,0.55,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">feron beta-1a (PEG-IFN) 125 µg administered every 2 or 4 </text>
   <text y="709.083" x="310.015,316.648,320.779,324.91,329.545,333.181,335.341,339.976,344.107,347.239,350.875,355.51,359.146,361.306,365.941,368.578,372.709,376.84,380.971,385.606,390.241,392.401,396.532,399.169,401.329,405.964,408.124,412.759,416.89,421.021,424.153,426.313,428.95,433.585,435.745,440.38,444.511,447.148,449.785,453.916,458.551,461.188,464.824,466.984,473.617,476.254,478.891,483.526,485.686,488.818,492.949,495.586,499.717,504.352,507.988,510.625,515.26,519.895,523.027,526.159,530.29,537.427,540.064,542.701" svgx:width="0.72,0.44,0.44,0.5,0.39,0.25,0.5,0.44,0.33,0.39,0.5,0.39,0.25,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.25,0.44,0.28,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.33,0.33,0.44,0.78,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">weeks versus placebo at 1 year in patients with relapsing-remit-</text>
   <text y="720.081" x="310.015,312.652,315.289,319.924,324.559,326.476,334.612,339.751,341.668,344.8,349.435,354.646,359.281,363.916,368.551,373.186,376.318,378.703,380.62,387.253,393.391,400.024,404.659,409.96,411.877,418.51,422.641,426.277,428.194,432.325,435.961,439.597,443.728,447.364,451.0,455.131,459.766,461.683,465.814,468.451,470.368,475.003,479.134,482.77,486.901,489.538,492.175,496.81,500.941,503.326,505.243,509.374,514.009,518.644,520.561,525.196,529.831,532.216,534.133,538.768,543.403,545.653" svgx:width="0.28,0.28,0.5,0.5,0.25,0.89,0.56,0.25,0.33,0.5,0.56,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.72,0.67,0.72,0.5,0.61,0.25,0.72,0.44,0.39,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.44,0.5,0.25,0.44,0.28,0.25,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.25,0.25,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ting MS (n=1512). HRQoL was assessed at baseline, and 12, 24, </text>
   <text y="731.079" x="310.015,314.146,318.781,323.416,325.198,329.833,334.468,336.25,342.883,347.014,351.145,355.78,359.416,361.198,365.833,369.469,372.106,376.741,381.376,383.158,387.793,389.575,392.212,396.847,400.483,403.12,406.252,410.887,418.024,422.155,426.79,429.427,433.063,435.7,437.482,440.119,444.754,448.885,450.667,458.803,463.438,466.075,468.712,471.349,475.984,478.621,482.752,484.534,489.673,493.804,496.441,500.572,503.704,508.339,511.975,514.612,518.248,520.03,523.162,530.299,534.934,539.065,543.196,545.698" svgx:width="0.44,0.5,0.5,0.25,0.5,0.5,0.25,0.72,0.44,0.44,0.5,0.39,0.25,0.5,0.39,0.28,0.5,0.5,0.25,0.5,0.25,0.28,0.5,0.39,0.28,0.33,0.5,0.78,0.44,0.5,0.28,0.39,0.28,0.25,0.28,0.5,0.44,0.25,0.89,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.56,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.33,0.78,0.5,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and 48 weeks using 3 instruments: the Multiple Sclerosis Impact </text>
  </g>
 </g>
</svg>
